<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>US Tele-Medicine Blog &#187; treatment of heart disease</title>
	<atom:link href="http://www.epatienthealthcare.com/blog/tag/treatment-of-heart-disease/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.epatienthealthcare.com/blog</link>
	<description>A Global Leader in Telemedicine</description>
	<lastBuildDate>Fri, 10 Feb 2012 21:55:04 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
		<item>
		<title>Natural Medicines in the Clinical Management of Heart Failure</title>
		<link>http://www.epatienthealthcare.com/blog/2010/10/11/natural-medicines-in-the-clinical-management-of-heart-failure/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/10/11/natural-medicines-in-the-clinical-management-of-heart-failure/#comments</comments>
		<pubDate>Tue, 12 Oct 2010 01:49:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Herbs]]></category>
		<category><![CDATA[Hormone Therapy]]></category>
		<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Longevity]]></category>
		<category><![CDATA[Medical Studies]]></category>
		<category><![CDATA[Nutritional Blends]]></category>
		<category><![CDATA[Vision]]></category>
		<category><![CDATA[Vitamins - Supplements]]></category>
		<category><![CDATA[alternative medicine]]></category>
		<category><![CDATA[cardiac function]]></category>
		<category><![CDATA[CHF]]></category>
		<category><![CDATA[chronic pain]]></category>
		<category><![CDATA[heart attack]]></category>
		<category><![CDATA[heart disease]]></category>
		<category><![CDATA[heart health]]></category>
		<category><![CDATA[herbal supplements]]></category>
		<category><![CDATA[mental anguish]]></category>
		<category><![CDATA[NOREPINEPHRINE]]></category>
		<category><![CDATA[supplements]]></category>
		<category><![CDATA[Tele-Medicine]]></category>
		<category><![CDATA[treatment of heart disease]]></category>
		<category><![CDATA[US Tele-Medicine Care Plan]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=1715</guid>
		<description><![CDATA[T THIS IS IS AN IN-DEPTH REVIEW SUITABLE FOR MEDICAL PRACTITIONERS Heart failure can be a bit tricky. Early symptoms are often so subtle they go undetected. By the time symptoms are noticed, there can be significant cardiac damage. By the time they are diagnosed, many patients have already lost up to 50% of their [...]]]></description>
			<content:encoded><![CDATA[<table id="ctl00_cphMain_tblCourse" border="0" cellpadding="0" width="625" align="center">
<tbody>
<tr>
<td height="25" align="center" valign="top">
<table style="height: 24px;" border="0" cellspacing="0" cellpadding="0" width="1" align="center">
<tbody>
<tr>
<td style="text-align: left;" height="55" valign="top">T</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td>
<table style="height: 6482px;" border="0" cellspacing="0" cellpadding="0" width="856" align="center">
<tbody>
<tr>
<td style="text-align: left;" colspan="3"><strong>THIS IS IS AN IN-DEPTH REVIEW SUITABLE FOR MEDICAL PRACTITIONERS</strong></td>
</tr>
<tr>
<td width="475" valign="top">
<table style="height: 1857px;" border="0" cellspacing="0" cellpadding="0" width="544">
<tbody>
<tr>
<td width="475" valign="top">Heart failure can be a bit tricky. Early symptoms are often so  subtle they go undetected. By the time symptoms are noticed, there can  be significant cardiac damage. By the time they are diagnosed, many  patients have already lost up to 50% of their cardiac function.<sup>12316</sup> As a result, survival time after diagnosis of heart failure is  relatively short&#8230;an average of 1.7 years for men and 3.2 years for  women.<sup>12317</sup></p>
<p>The sooner heart failure is detected, the better. Suspect heart failure  in patients with poorly-controlled or long-standing hypertension,  valvular disease, or coronary artery disease. An echocardiogram can give  an early indication of heart failure even in patients who don&#8217;t have  symptoms. The diagnosis can often be confirmed with further testing,  such as an exercise test.<sup>12316</sup></p>
<p>Heart failure develops with a snowball effect. Symptoms beget more  symptoms. When the heart starts to fail, the body tries to compensate.  As cardiac output decreases, the adrenergic system kicks in and  norepinephrine levels increase. At first, the increased adrenergic  stimulation helps maintain cardiac output. Over time the adrenergic  stimulation starts to work against the heart. Norepinephrine increases  arterial pressure. Eventually the heart must contract more forcefully to  overcome increased arterial pressure. The increased norepinephrine also  stimulates production of renin in the kidney. Renin is important in the  conversion of angiotensinogen to angiotensin I. And angiotensin I is  converted by angiotensin-converting enzyme (ACE) to angiotensin II.  Angiotensin II further increases arterial pressure and causes structural  changes in the heart. The structural changes are known as &#8220;cardiac  remodeling.&#8221; Ultimately, these effects put additional stress on the  heart, increase cardiac cell death, and cause disease progression.<sup>12318</sup></p>
<p>Many of the treatments used for heart failure target these  processes&#8230;and ultimately slow the snowball effect. The goal of  treatment is to slow the progression of the disease.</p>
<table id="Table3" border="1" cellspacing="0" cellpadding="2" width="99%" align="center">
<tbody>
<tr>
<td width="99%" align="middle"><strong>Commonly Used Conventional and Natural Medicines for Heart Failure*</strong></td>
</tr>
<tr>
<td><strong><span style="text-decoration: underline;">Renin-Angiotensin-Aldosterone System (RAAS) Blockers</span></strong><br />
<strong>Angiotensin-Converting Enzyme (ACE) Inhibitors</strong><br />
<span style="text-decoration: underline;">Conventional Medicines</span><br />
Benazepril (<em>Lotensin</em>)<br />
Captopril (<em>Capoten</em>)<br />
Enalapril (<em>Vasotec</em>)<br />
Fosinopril (<em>Monopril</em>)<br />
Lisinopril (<em>Zestril</em> / <em>Prinivil</em>)<br />
Moexipril (<em>Univasc</em>)<br />
Perindopril (<em>Aceon</em>)<br />
Quinapril (<em>Accupril</em>)<br />
Ramipril (<em>Altace</em>)<br />
Trandolapril (<em>Mavik</em>)<br />
<span style="text-decoration: underline;">Natural Medicines</span><br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=875&amp;view=m" target="monograph"><strong>L-arginine</strong></a><br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=392&amp;view=m" target="monograph"><strong>Pomegranate</strong></a> (<em>Punica granatum</em>)<br />
<strong>Angiotensin II Receptor Blockers (ARBs)</strong><br />
<span style="text-decoration: underline;">Conventional Medicines</span><br />
Candesartan (<em>Atacand</em>)<br />
Eprosartan (<em>Teveten</em>)<br />
Irbesartan (<em>Avapro</em>)<br />
Losartan (<em>Cozaar</em>)<br />
Olmesartan (<em>Benicar</em>)<br />
Telmisartan (<em>Micardis</em>)<br />
Valsartan (<em>Diovan</em>)<br />
<strong>Aldosterone Blockers</strong><br />
<span style="text-decoration: underline;">Conventional Medicines</span><br />
Spironolactone (<em>Aldactone</em>)</td>
</tr>
<tr>
<td><strong><span style="text-decoration: underline;">Adrenergic System Blockers</span></strong><br />
<strong>Beta-blockers</strong><br />
<span style="text-decoration: underline;">Conventional Medicines</span><br />
Atenolol (<em>Tenormin</em>)<br />
Bisoprolol (<em>Zebeta</em>)<br />
Carvedilol (<em>Coreg</em>)<br />
Metoprolol (<em>Toprol XL</em>)<br />
Propranolol (<em>Inderal</em>)</td>
</tr>
<tr>
<td><strong><span style="text-decoration: underline;">Diuretics</span></strong><br />
<span style="text-decoration: underline;">Conventional Medicines</span><br />
Eplerenone (<em>Inspra</em>)<br />
Furosemide (<em>Lasix</em>)<br />
Hydrochlorothiazide (<em>Microzide</em>)<br />
Spironolactone (<em>Aldactone</em>)<br />
<span style="text-decoration: underline;">Natural Medicines</span><br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=140&amp;view=m" target="monograph"><strong>Corn silk</strong></a> (<em>Zea mays</em>)<br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=706&amp;view=m" target="monograph"><strong>Dandelion</strong></a> (<em>Taraxacum officinale</em>)<br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=664&amp;view=m" target="monograph"><strong>Stinging nettle</strong></a> (<em>Urtica dioica</em>)</td>
</tr>
<tr>
<td><strong><span style="text-decoration: underline;">Cardiac Positive Inotropes</span></strong><br />
<strong>Cardiac Glycosides</strong><br />
<span style="text-decoration: underline;">Conventional Medicines</span><br />
Digoxin (<em>Lanoxin</em>)<br />
<span style="text-decoration: underline;">Natural Medicines</span><br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=287&amp;view=m" target="monograph"><strong>Digitalis</strong></a> (<em>Digitalis purpurea</em>)<br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=527&amp;view=m" target="monograph"><strong>Hawthorn</strong></a> (<em>Crataegus monogyna</em>)<br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=789&amp;view=m" target="monograph"><strong>Oleander</strong></a> (<em>Nerium oleander</em>)<br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=183&amp;view=m" target="monograph"><strong>Pheasant&#8217;s eye</strong></a> (<em>Adonis vernalis</em>)<br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=743&amp;view=m" target="monograph"><strong>Squill</strong></a> (<em>Urginea indica</em>)<br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=1163&amp;view=m" target="monograph"><strong>Star of Bethlehem</strong></a> (<em>Ornithogalum umbellatum</em>)<br />
<strong>Others</strong><br />
<span style="text-decoration: underline;">Natural Medicines</span><br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=1026&amp;view=m" target="monograph"><strong>Carnitine</strong></a><br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=873&amp;view=m" target="monograph"><strong>Creatine</strong></a><br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=803&amp;view=m" target="monograph"><strong>Propionyl-L-carnitine</strong></a><br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=811&amp;view=m" target="monograph"><strong>Terminalia</strong></a> (<em>Terminalia arjuna</em>)</td>
</tr>
<tr>
<td><strong><span style="text-decoration: underline;">Vasodilators</span></strong><br />
<span style="text-decoration: underline;">Conventional Medicines</span><br />
Hydralazine (<em>Apresoline</em>)<br />
Hydralazine + Isosorbide dinitrate (<em>BiDil</em>)<br />
Isosorbide dinitrate (<em>Isordil</em>)</td>
</tr>
<tr>
<td><strong><span style="text-decoration: underline;">Miscellaneous</span></strong><br />
<span style="text-decoration: underline;">Natural Medicines</span><br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=938&amp;view=m" target="monograph"><strong>Coenzyme Q-10</strong></a><br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=875&amp;view=m" target="monograph"><strong>L-arginine</strong></a><br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=998&amp;view=m" target="monograph"><strong>Magnesium</strong></a><br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=1024&amp;view=m" target="monograph"><strong>Taurine</strong></a><br />
<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=965&amp;view=m" target="monograph"><strong>Thiamine</strong></a> (<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=965&amp;view=m" target="monograph"><strong>Vitamin B1</strong></a>)</td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="2" width="99%" align="center">
<tbody>
<tr>
<td><span><strong>*Note:</strong> Many natural products are  tried for heart failure, but very few have reliable evidence that they  work. Inclusion in this list does NOT imply that these products are  effective for heart failure.</span></td>
</tr>
</tbody>
</table>
<p>Only a few conventional treatments are actually proven to slow disease  progression and improve survival. They fall into two categories: 1.)  renin-angiotensin-aldosterone system (RAAS) blockers; and 2.) adrenergic  system blockers.</p>
<p>To read more about <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceCourseLinks.aspx?page=view_ddpu&amp;dd=180109" target="_blank">heart failure guidelines</a> see <em>Pharmacist&#8217;s Letter</em> / <em>Prescriber&#8217;s Letter</em> <em>Detail-Document</em> #180109.</td>
</tr>
</tbody>
</table>
</td>
<td width="10"></td>
<td width="130" height="20" valign="top" bgcolor="#fff5cc">
<table border="0" cellspacing="0" cellpadding="0" width="130">
<tbody>
<tr>
<td width="130">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tbody>
<tr>
<td></td>
</tr>
<tr>
<td valign="top">
<table style="height: 4px;" cellspacing="0" cellpadding="0" width="1" align="center">
<tbody>
<tr>
<td colspan="2" height="50"></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td height="50" align="center"></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="130">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tbody>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="5" /></td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="475" valign="top">
<table border="0" cellspacing="0" cellpadding="0" width="475">
<tbody>
<tr>
<td width="475" valign="top"><a name="1333"></a></p>
<table border="0" cellspacing="0" cellpadding="0" width="470">
<tbody>
<tr height="22">
<td width="440" bgcolor="#ffdd77">Renin-Angiotensin-Aldosterone System (RAAS) Blockers</td>
<td width="25" bgcolor="#ffdd77"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceCourse.aspx?s=ND&amp;cs=&amp;pc=07%2D32&amp;cec=1&amp;pm=5#top"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/btn_top-trans.gif" border="0" alt="return to top" /></a></td>
<td></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="475" valign="top">The RAAS blockers include three classes of drugs:</p>
<ul>
<li>Angiotensin-converting enzyme (ACE) inhibitors</li>
<li>Angiotensin II receptor blockers (ARBs)</li>
<li>Spironolactone and eplerenone (<em>Inspra</em>)</li>
</ul>
<p>People used to think ACE inhibitors (e.g., <em>Monopril</em>, <em>Vasotec</em>,  etc) worked because they cause vasodilation and decrease arterial  pressure. We now know that ACE inhibitors do more. They block production  of angiotensin II, and that helps prevent cardiac remodeling. Treatment  with ACE inhibitors improves symptoms and can decrease death rate by up  to 23%.<sup>12318</sup></p>
<p>An angiotensin II receptor blocker (e.g., <em>Atacand</em>, <em>Avapro</em>, <em>Cozaar</em>, <em>Diovan</em>,  etc) can be substituted for patients who can&#8217;t tolerate an ACE  inhibitor. There&#8217;s growing evidence that these drugs also improve  survival.<sup>12320</sup></p>
<p>Spironolactone (<em>Aldactone</em>) is a potassium-sparing diuretic. It  causes diuresis, but works in a unique way that also seems to interrupt  one of the &#8220;snowball effects&#8221; of heart failure. Spironolactone blocks  aldosterone. Aldosterone levels increase in patients with heart failure,  which leads to fluid retention, fluid overload, and worsening of  symptoms. Adding spironolactone to heart failure patients already on an  ACE inhibitor and other diuretics can reduce symptoms and mortality by  about 30%.<sup>12321</sup></p>
<p>An alternative to spironolactone is the newer drug eplerenone (<em>Inspra</em>). It works like spironolactone, but is more selective for aldosterone receptors&#8230;and therefore causes fewer side effects.</p>
<p>To read more about <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceCourseLinks.aspx?page=view_ddpu&amp;dd=191104" target="_blank">eplerenone</a> see <em>Pharmacist&#8217;s Letter</em> / <em>Prescriber&#8217;s Letter</em> <em>Detail-Document</em> #191104.</p>
<table border="1" cellspacing="0" cellpadding="2" width="85%" align="center">
<tbody>
<tr>
<td bgcolor="#fff5cc"><strong>Practice Pearl</strong></td>
</tr>
<tr>
<td>Watch for hyperkalemia in patients who get  spironolactone or eplerenone&#8230;especially when they are combined with an  ACE inhibitor, ARB, or another drug that increases potassium.  Inappropriate monitoring of patients on spironolactone has been linked  to increased hospitalizations and death due to hyperkalemia.<sup>12322</sup></td>
</tr>
</tbody>
</table>
<p>Several natural medicines are promoted and used for cardiovascular  conditions such as heart failure. Some of these products affect the  renin-angiotensin-aldosterone system.</p>
<p><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=875&amp;view=m" target="monograph"><strong>L-arginine</strong></a> is one of the best known natural medicines used for cardiovascular  disease. The most common explanation for its cardiovascular benefits has  to do with L-arginine&#8217;s affect on nitric oxide. L-arginine is a  substrate for the enzyme nitric oxide synthase (NOS). The enzyme  converts L-arginine to nitric oxide. This leads to vasodilation,  improved coronary endothelial function, and increased coronary blood  flow.<sup>110,116,1362,1363,3330</sup></p>
<p>In addition to increasing nitric oxide, there is some evidence that  L-arginine decreases the activity of the angiotensin-converting enzyme  (ACE).<sup>7820</sup> Theoretically, this could have benefits in interrupting the snowball effect of congestive heart failure.</p>
<p>Despite these promising pharmacological effects, the clinical benefits  of L-arginine are limited. When L-arginine is added to conventional  treatment, heart failure patients seem to have improved kidney function  and increase fluid elimination.<sup>3596</sup> Some patients also have  improved functional status, exercise tolerance, and quality of life, but  these benefits have not been found consistently in clinical trials.<sup>3595,6028,7813,8014</sup></p>
<p>L-arginine seems promising, but there&#8217;s not much known about it&#8217;s  long-term benefits&#8230;or if L-arginine can improve ultimate outcomes. For  now, don&#8217;t recommend it for most patients. But if patients decide to  try it, don&#8217;t worry too much, L-arginine is usually safe for most  patients. Advise patients who use L-arginine that high doses are usually  needed&#8230; 6-20 grams per day. Explain that adding L-arginine might  cause a decrease in blood pressure. This could lead to hypotension in  some patients, especially if they are taking other antihypertensives.</p>
<p><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=392&amp;view=m" target="monograph"><strong>Pomegranate</strong></a> (<em>Punica granatum</em>) doesn&#8217;t sound all that appetizing to many of us. But pomegranate juice is now becoming a popular healthy drink. Products like <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=ceCHF&amp;brand_id=11320&amp;view=bn" target="monograph"><em>POM Wonderful</em></a> are being promoted by the fact that pomegranate juice has lots of  polyphenols that work as antioxidants. There are more of these healthy  polyphenols in pomegranate juice than in <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=960&amp;view=m" target="monograph"><strong>green tea</strong></a>, <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=908&amp;view=m" target="monograph"><strong>orange juice</strong></a>, or <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=989&amp;view=m" target="monograph"><strong>red wine</strong></a>.</p>
<p>But the evidence for cardiovascular benefits in humans is still just  ramping up. There is preliminary evidence that it can decrease  angiotensin-converting enzyme (ACE) activity. Some evidence also  suggests that drinking pomegranate juice 50 mL/day might help decrease  blood pressure by about 5% in patients with hypertension.<sup>8310</sup></p>
<p>Since pomegranate juice decreases ACE, there is potential for its use in  heart failure. But so far this hasn&#8217;t been studied. If heart failure  patients want to drink the juice, no problem. There&#8217;s no question that  it&#8217;s a healthy drink. Just advise them not to rely on it for improved  heart failure symptoms.</td>
</tr>
</tbody>
</table>
</td>
<td width="10"></td>
<td width="130" height="20" valign="top" bgcolor="#fff5cc">
<table border="0" cellspacing="0" cellpadding="0" width="130">
<tbody>
<tr>
<td width="130">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tbody>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="285" /></td>
</tr>
<tr>
<td valign="top">
<table width="96%" align="center">
<tbody>
<tr>
<td colspan="2" height="20" bgcolor="#ffdd77"><span style="color: black;"> <strong> Question #1</strong></span></td>
</tr>
<tr>
<td colspan="2">ACE inhibitors</td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q1A">a. work in heart failure by decreasing arterial pressure.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q1B">b. help to prevent cardiac remodeling.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q1C">c. improve symptoms and reduce death.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q1D">d. All of the above</label></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="200" /></td>
</tr>
<tr>
<td>
<table cellspacing="0" cellpadding="1" width="122" align="center">
<tbody>
<tr bgcolor="white">
<td colspan="2" align="center"><strong>View brands containing:</strong></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=875" target="monograph">L-arginine</a></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="55" /></td>
</tr>
<tr>
<td valign="top">
<table width="96%" align="center">
<tbody>
<tr>
<td colspan="2" height="20" bgcolor="#ffdd77"><span style="color: black;"> <strong> Question #2</strong></span></td>
</tr>
<tr>
<td colspan="2">Which of the following drugs is L-arginine most likely to interact with? (HINT: <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=875&amp;view=m" target="monograph"><strong>click here</strong></a> to go to the L-arginine monograph; then scroll down to the <em>Interactions with Drugs</em> section)</td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q2A">a. Warfarin</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q2B">b. Digoxin</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q2C">c. Sildenafil </label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q2D">d. Zolpidem</label></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="49" /></td>
</tr>
<tr>
<td>
<table cellspacing="0" cellpadding="1" width="122" align="center">
<tbody>
<tr bgcolor="white">
<td colspan="2" align="center"><strong>View brands containing:</strong></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=392" target="monograph">Pomegranate</a></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=960" target="monograph">Green tea</a></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=908" target="monograph">Orange juice</a></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=989" target="monograph">Red wine</a></td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="475" valign="top">
<table border="0" cellspacing="0" cellpadding="0" width="475">
<tbody>
<tr>
<td width="475" valign="top"><a name="1334"></a></p>
<table border="0" cellspacing="0" cellpadding="0" width="470">
<tbody>
<tr height="22">
<td width="440" bgcolor="#ffdd77">Adrenergic System Blockers</td>
<td width="25" bgcolor="#ffdd77"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceCourse.aspx?s=ND&amp;cs=&amp;pc=07%2D32&amp;cec=1&amp;pm=5#top"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/btn_top-trans.gif" border="0" alt="return to top" /></a></td>
<td></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="475" valign="top">The second category of drugs includes those that target the adrenergic system, beta-blockers.</p>
<p>Beta-blockers are now considered essential in heart failure. We used to  think beta-blockers would worsen heart failure, so clinicians weren&#8217;t  using them. Now there&#8217;s proof that at least some beta-blockers (<em>Coreg</em>, <em>Toprol XL</em>, <em>Zebeta</em>)  can save lives. Beta-blockers block the adrenergic system that revs up  in patients with heart failure and can often lead to serious  arrhythmias. Adding a beta-blocker can reduce mortality by up to 34%.<sup>12318</sup></p>
<p>Most patients should be started on an ACE inhibitor, even when they are  asymptomatic. Beta-blockers should be added for improved prevention of  disease progression and improved survival benefits.<sup>12319</sup> But  don&#8217;t add beta-blockers in &#8220;decompensated&#8221; patients&#8230;those with  pulmonary edema, etc. Beta-blockers can initially worsen these symptoms.</td>
</tr>
</tbody>
</table>
</td>
<td width="10"></td>
<td width="130" height="20" valign="top" bgcolor="#fff5cc">
<table border="0" cellspacing="0" cellpadding="0" width="130">
<tbody>
<tr>
<td width="130">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tbody>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="35" /></td>
</tr>
<tr>
<td valign="top">
<table width="96%" align="center">
<tbody>
<tr>
<td colspan="2" height="20" bgcolor="#ffdd77"><span style="color: black;"> <strong> Question #3</strong></span></td>
</tr>
<tr>
<td colspan="2">Which of the following primarily affects the renin-angiotensin-aldosterone system?</td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q3A">a. Ramipril</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q3B">b. <em>Coreg</em></label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q3C">c. Pomegranate</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q3D">d. A and C</label></td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="475" valign="top">
<table border="0" cellspacing="0" cellpadding="0" width="475">
<tbody>
<tr>
<td width="475" valign="top"><a name="1335"></a></p>
<table border="0" cellspacing="0" cellpadding="0" width="470">
<tbody>
<tr height="22">
<td width="440" bgcolor="#ffdd77">Diuretics</td>
<td width="25" bgcolor="#ffdd77"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceCourse.aspx?s=ND&amp;cs=&amp;pc=07%2D32&amp;cec=1&amp;pm=5#top"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/btn_top-trans.gif" border="0" alt="return to top" /></a></td>
<td></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="475" valign="top">A lot of patients with heart failure need a diuretic to reduce fluid retention&#8230;furosemide (<em>Lasix</em>), hydrochlorothiazide (<em>Microzide</em>), etc.</p>
<p>Some patients also turn to natural medicines to help with fluid  retention. Several natural medicines are reported to have diuretic  effects. <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=706&amp;view=m" target="monograph"><strong>Dandelion</strong></a> (<em>Taraxacum officinale</em>) is one of the most common herbal diuretics recommended for edema. Others include <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=140&amp;view=m" target="monograph"><strong>corn silk</strong></a> (<em>Zea mays</em>) and <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=664&amp;view=m" target="monograph"><strong>stinging nettle</strong></a> (<em>Urtica dioica</em>).</p>
<p>While tradition suggests that these herbs have diuretic properties,  there is no reliable evidence that they reduce edema in patients with  heart failure. Advise patients not to use them.</p>
<p><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=965&amp;view=m" target="monograph"><strong>Thiamine</strong></a> and <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=998&amp;view=m" target="monograph"><strong>magnesium</strong></a> are sometimes recommended for heart failure patients who take  conventional diuretics. That&#8217;s because diuretics can deplete levels of  these nutrients.</p>
<p>Thiamine (vitamin B1) deficiency can worsen heart failure.<sup>1284,1285,1286,10507</sup> This deficiency is most common in the elderly.<sup>10506</sup> Elderly patients taking loop diuretics who continue to have symptoms  despite adequate treatment might benefit from thiamine supplements.<sup>1284,1286,10508</sup> Consider adding thiamine in these patients&#8230; 50-200 mg per day.</p>
<p>Magnesium deficiency is particularly concerning in heart failure  patients who are also taking digoxin. Low magnesium levels can increase  the risk of digoxin toxicity.<sup>9613,9614</sup> Consider checking  magnesium levels in elderly patients who have been taking diuretics  chronically. Also, make sure magnesium levels are checked in heart  failure patients who have had arrhythmias&#8230;low magnesium levels could  be a contributing factor. Add a magnesium supplement for patients who  are deficient&#8230; 20-130 mg daily.<sup>6430</sup></td>
</tr>
</tbody>
</table>
</td>
<td width="10"></td>
<td width="130" height="20" valign="top" bgcolor="#fff5cc">
<table border="0" cellspacing="0" cellpadding="0" width="130">
<tbody>
<tr>
<td width="130">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tbody>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="125" /></td>
</tr>
<tr>
<td>
<table cellspacing="0" cellpadding="1" width="122" align="center">
<tbody>
<tr bgcolor="white">
<td colspan="2" align="center"><strong>View brands containing:</strong></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=706" target="monograph">Dandelion</a></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=140" target="monograph">Corn silk</a></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=664" target="monograph">Stinging nettle</a></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=965" target="monograph">Thiamine</a></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=998" target="monograph">Magnesium</a></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="32" /></td>
</tr>
<tr>
<td valign="top">
<table width="96%" align="center">
<tbody>
<tr>
<td colspan="2" height="20" bgcolor="#ffdd77"><span style="color: black;"> <strong> Question #4</strong></span></td>
</tr>
<tr>
<td colspan="2">Thiamine is sometimes recommended for heart failure patients because:</td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q4A">a. It increases ejection fraction.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q4B">b. It prevents digoxin side effects.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q4C">c. It is depleted by diuretics.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q4D">d. It improves survival.</label></td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="475" valign="top">
<table border="0" cellspacing="0" cellpadding="0" width="475">
<tbody>
<tr>
<td width="475" valign="top"><a name="1336"></a></p>
<table border="0" cellspacing="0" cellpadding="0" width="470">
<tbody>
<tr height="22">
<td width="440" bgcolor="#ffdd77">Cardiac Positive Inotropes</td>
<td width="25" bgcolor="#ffdd77"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceCourse.aspx?s=ND&amp;cs=&amp;pc=07%2D32&amp;cec=1&amp;pm=5#top"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/btn_top-trans.gif" border="0" alt="return to top" /></a></td>
<td></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="475" valign="top">Digoxin (<em>Lanoxin</em>)  is a good example of a natural medicine that is no longer an  &#8220;alternative medicine.&#8221; Digoxin is a cardiac glycoside derived from the <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=287&amp;view=m" target="monograph"><strong><em>Digitalis purpurea</em></strong></a> plant&#8230;also known as <strong>foxglove</strong>.  Digoxin can increase intracellular calcium in cardiac cells. This  increases contractility and cardiac output. Digoxin is typically added  as symptoms progress, but it does not reduce mortality.</p>
<table border="1" cellspacing="0" cellpadding="2" width="85%" align="center">
<tbody>
<tr>
<td bgcolor="#fff5cc"><strong>Practice Pearl</strong></td>
</tr>
<tr>
<td>Help make sure patients who get digoxin get an  appropriate dose. There is some concern that doses that are too high  might INCREASE mortality in women. Usually doses of 0.125 mg/day are  adequate. Serum levels should be maintained between 0.5-1.0 ng/mL.</td>
</tr>
</tbody>
</table>
<p>To read more about <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceCourseLinks.aspx?page=view_ddpu&amp;dd=181203" target="_blank">gender difference related to digoxin</a> see <em>Pharmacist&#8217;s Letter</em> / <em>Prescriber&#8217;s Letter</em> <em>Detail-Document</em> #181203.</p>
<p>Several other plants contain cardiac glycosides&#8230;<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=789&amp;view=m" target="monograph"><strong>oleander</strong></a>, <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=183&amp;view=m" target="monograph"><strong>pheasant&#8217;s eye</strong></a>, <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=743&amp;view=m" target="monograph"><strong>squill</strong></a>, <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=1163&amp;view=m" target="monograph"><strong>star of Bethlehem</strong></a> and others. Anecdotally, they may help,<sup>15331,15332</sup> but none of these have been studied in clinical trials&#8230;and none are  appropriate for self-treatment of heart failure. Due to the lack of  stringent manufacturing standards, these herbal products would likely  contain an inconsistent amount of the active cardiac glycosides and  produce inconsistent results. Fortunately, formulations of these plants  are almost never found in supplements sold on store shelves.</p>
<p><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=1026&amp;view=m" target="monograph"><strong>Carnitine</strong></a> seems to have a positive inotropic effect, but it&#8217;s much different than  the cardiac glycosides. Carnitine is an amino acid-like cofactor in  skeletal muscles and the heart. It is involved in generating energy  within the cells. Carnitine helps move long-chain fatty acids into  mitochondria where they are converted to energy.</p>
<p>Patients with heart failure and other cardiovascular conditions seem to have decreased levels of this cofactor in heart tissue.<sup>1572</sup> Some researchers think carnitine levels might be a disease marker for  heart failure&#8230;lower levels usually indicate more severe heart failure.<sup>12323</sup></p>
<p>The clinical evidence looks promising. Carnitine seems to improve  symptoms, ejection fraction, and exercise tolerance. Carnitine seems to  increase ejection fraction by up to 14% and exercise tolerance by as  much as 21% in some patients.<sup>1575,1582,1583,3626</sup> In some patients carnitine also seems to decrease cardiac remodeling.<sup>1575</sup></p>
<p>There&#8217;s even some preliminary evidence that carnitine might slow the disease process and improve survival.<sup>3625</sup></p>
<p>The body of evidence supporting carnitine is growing, but it&#8217;s still  fairly preliminary. There&#8217;s not enough support to recommend it across  the board. But it might be worth a try in patients who are not improving  on standard therapy. Some clinicians are using 1.5-2 grams, usually  divided and given 2-3 times daily. Two different formulations are being  used&#8230;<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=1026&amp;view=m" target="monograph"><strong>L-carnitine</strong></a> and <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=803&amp;view=m" target="monograph"><strong>propionyl-L-carnitine</strong></a>.  Both have been used in studies, but there&#8217;s some speculation that  propionyl-L-carnitine might deliver carnitine to the cells more  efficiently.<sup>1439</sup></p>
<p>Tell patients who take carnitine that it might take 2 weeks to a month  for significant symptom improvement. Maximum improvement can take up to 6  months.</p>
<p><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=873&amp;view=m" target="monograph"><strong>Creatine</strong></a> is a very popular sports supplement. Athletes often use it to bulk up  or improve athletic performance. Now some people are using it in  patients with heart failure&#8230;to improve exercise tolerance. There&#8217;s  some evidence that it can help improve strength and endurance in heart  failure patients.<sup>4562,4563</sup></p>
<p>But there are safety concerns with creatine and some unanswered  questions. Creatine is probably not a good choice for patients with  heart failure. Taking creatine requires drinking extra fluids to prevent  dehydration and cramping. Fluid overload is a problem with heart  failure patients. So increasing fluid intake is usually avoided. Also,  people with heart failure are prone to renal disease. There is some  concern that creatine might contribute to worsening renal function.<sup>184,2118</sup> Advise heart failure patients to avoid creatine.</p>
<p><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=527&amp;view=m" target="monograph"><strong>Hawthorn</strong></a> (<em>Crataegus monogyna</em>)  is an herb with a long history of use in Europe. Many clinicians in  Europe consider hawthorn a preferred alternative to digoxin. Hawthorn  seems to have many of the same benefits as digoxin. It increases cardiac  output and exercise tolerance and reduces symptoms. Specific extracts  of hawthorn (<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=ceCHF&amp;brand_id=23852&amp;view=bn" target="monograph"><em>Crataegutt</em></a> and <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=ceCHF&amp;brand_id=23867&amp;view=bn" target="monograph"><em>Faros 300</em></a>) seem to be helpful in the early stages of heart failure.<sup>8279,8280,10144,11449</sup> But it might not offer much benefit in patients with more severe disease.</p>
<p>Hawthorn contains constituents that increase heart contraction and coronary blood flow, and cause vasodilation.<sup>406,10144,11450</sup> Some people claim that hawthorn is actually better than digoxin. They  say it&#8217;s less likely to induce arrhythmias, safer in renal dysfunction,  and better tolerated overall. But there&#8217;s no solid evidence this is  true.</p>
<p>You can think of hawthorn as a &#8220;milder digoxin.&#8221; It&#8217;s not appropriate  for self-treatment. If you consider using it for your patients, hawthorn  should only be considered early on in the disease, when symptoms aren&#8217;t  too severe and BEFORE patients require digoxin. There&#8217;s no benefit to  adding it in patients already taking digoxin. Doses of hawthorn extract  are typically 200-500 mg three times daily. Keep in mind that it can  take 6-8 weeks before there is maximal benefit. Tell patients that as  symptoms get worse, they&#8217;ll eventually need to be switched to digoxin.</p>
<p>You might see patients trying another herb for heart failure&#8230;<a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=811&amp;view=m" target="monograph"><strong>terminalia</strong></a> (<em>Terminalia arjuna</em>), also known as <strong>arjuna</strong>. There is some evidence it can improve heart function and decrease symptoms.<sup>2504</sup> Some researchers think it might increase heart rate and cardiac output.  Terminalia looks promising, but don&#8217;t recommend it yet. More evidence  is needed about long-term safety and effectiveness.</p>
<p>THANKS TO THE NATURAL DATABASE.COM FOR THIS INFORMATION</td>
</tr>
</tbody>
</table>
</td>
<td width="10"></td>
<td width="130" height="20" valign="top" bgcolor="#fff5cc">
<table border="0" cellspacing="0" cellpadding="0" width="130">
<tbody>
<tr>
<td width="130">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tbody>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="35" /></td>
</tr>
<tr>
<td>
<table cellspacing="0" cellpadding="1" width="122" align="center">
<tbody>
<tr bgcolor="white">
<td colspan="2" align="center"><strong>View brands containing:</strong></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=287" target="monograph">Digitalis</a></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="215" /></td>
</tr>
<tr>
<td>
<table cellspacing="0" cellpadding="1" width="122" align="center">
<tbody>
<tr bgcolor="white">
<td colspan="2" align="center"><strong>View brands containing:</strong></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=789" target="monograph">Oleander</a></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=183" target="monograph">Pheasant&#8217;s eye</a></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=743" target="monograph">Squill</a></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=1163" target="monograph">Star Of Bethlehem</a></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=1026" target="monograph">Carnitine</a></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="10" /></td>
</tr>
<tr>
<td valign="top">
<table width="96%" align="center">
<tbody>
<tr>
<td colspan="2" height="20" bgcolor="#ffdd77"><span style="color: black;"> <strong> Question #5</strong></span></td>
</tr>
<tr>
<td colspan="2">Which of the following is most similar to digoxin?</td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q5A">a. Squill</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q5B">b. L-arginine</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q5C">c. Pomegranate</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q5D">d. Corn silk</label></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="110" /></td>
</tr>
<tr>
<td>
<table cellspacing="0" cellpadding="1" width="122" align="center">
<tbody>
<tr bgcolor="white">
<td colspan="2" align="center"><strong>View brands containing:</strong></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=1026" target="monograph">L-carnitine</a></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=803" target="monograph">Propionyl-L-carnitine</a></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="5" /></td>
</tr>
<tr>
<td valign="top">
<table width="96%" align="center">
<tbody>
<tr>
<td colspan="2" height="20" bgcolor="#ffdd77"><span style="color: black;"> <strong> Question #6</strong></span></td>
</tr>
<tr>
<td colspan="2">Which of the following is TRUE regarding carnitine?</td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q6A">a. Lower levels of carnitine are associated with worsening heart failure.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q6B">b. Preliminary evidence shows that carnitine might improve survival in heart failure patients.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q6C">c. Typical doses are 1.5-2 grams divided and given 2-3 times daily.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q6D">d. All of the above</label></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="5" /></td>
</tr>
<tr>
<td>
<table cellspacing="0" cellpadding="1" width="122" align="center">
<tbody>
<tr bgcolor="white">
<td colspan="2" align="center"><strong>View brands containing:</strong></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=873" target="monograph">Creatine</a></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=527" target="monograph">Hawthorn</a></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="5" /></td>
</tr>
<tr>
<td valign="top">
<table width="96%" align="center">
<tbody>
<tr>
<td colspan="2" height="20" bgcolor="#ffdd77"><span style="color: black;"> <strong> Question #7</strong></span></td>
</tr>
<tr>
<td colspan="2">Which of the following is TRUE about creatine?</td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q7A">a. It can improve exercise tolerance in heart failure patients.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q7B">b. It needs to be taken with plenty of fluid.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q7C">c. It might contribute to worsening renal function in heart failure patients.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q7D">d. All of the above</label></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="5" /></td>
</tr>
<tr>
<td>
<table cellspacing="0" cellpadding="1" width="122" align="center">
<tbody>
<tr bgcolor="white">
<td colspan="2" align="center"><strong>View brands containing:</strong></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=811" target="monograph">Terminalia</a></td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="475" valign="top">
<table border="0" cellspacing="0" cellpadding="0" width="475">
<tbody>
<tr>
<td width="475" valign="top"><a name="1337"></a></p>
<table border="0" cellspacing="0" cellpadding="0" width="470">
<tbody>
<tr height="22">
<td width="440" bgcolor="#ffdd77">Vasodilators</td>
<td width="25" bgcolor="#ffdd77"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceCourse.aspx?s=ND&amp;cs=&amp;pc=07%2D32&amp;cec=1&amp;pm=5#top"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/btn_top-trans.gif" border="0" alt="return to top" /></a></td>
<td></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="475" valign="top">The vasodilators hydralazine (<em>Apresoline</em>) and isosorbide dinitrate (<em>Isordil</em>)  were commonly used for heart failure many years ago&#8230;before we started  using ACE inhibitors and beta-blockers. Now they are making a  comeback&#8230;especially for African Americans. There are concerns that ACE  inhibitors and beta-blockers don&#8217;t work as well for blacks as for  whites. Black patients with moderate to severe heart failure, who get  hydralazine plus isosorbide dinitrate (<em>BiDil</em>) along with standard treatment, seem to have improved survival.</p>
<p>To read more about <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceCourseLinks.aspx?page=view_ddpu&amp;dd=210105" target="_blank">using hydralazine plus isosorbide dinitrate for heart failure</a> see <em>Pharmacist&#8217;s Letter</em> / <em>Prescriber&#8217;s Letter</em> <em>Detail-Document</em> #210105.</td>
</tr>
</tbody>
</table>
</td>
<td width="10"></td>
<td width="130" height="20" valign="top" bgcolor="#fff5cc">
<table border="0" cellspacing="0" cellpadding="0" width="130">
<tbody>
<tr>
<td width="130">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tbody>
<tr>
<td valign="top">
<table width="96%" align="center">
<tbody>
<tr>
<td colspan="2" height="20" bgcolor="#ffdd77"><span style="color: black;"> <strong> Question #8</strong></span></td>
</tr>
<tr>
<td colspan="2">A heart failure patient who is taking digoxin wants to use hawthorn. What should you tell him?</td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q8A">a. The appropriate dose is 200-500 mg daily.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q8B">b. Use the clinically studied brand, <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=ceCHF&amp;brand_id=23852&amp;view=bn" target="monograph"><em>Crataegutt</em></a>.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q8C">c. It probably won&#8217;t help.</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q8D">d. Use arjuna instead.</label></td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="475" valign="top">
<table border="0" cellspacing="0" cellpadding="0" width="475">
<tbody>
<tr>
<td width="475" valign="top"><a name="1338"></a></p>
<table border="0" cellspacing="0" cellpadding="0" width="470">
<tbody>
<tr height="22">
<td width="440" bgcolor="#ffdd77">Miscellaneous</td>
<td width="25" bgcolor="#ffdd77"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceCourse.aspx?s=ND&amp;cs=&amp;pc=07%2D32&amp;cec=1&amp;pm=5#top"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/btn_top-trans.gif" border="0" alt="return to top" /></a></td>
<td></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="475" valign="top"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=938&amp;view=m" target="monograph"><strong>Coenzyme Q-10</strong></a> is one of the most talked about supplements used for heart failure and  many other conditions. The theory about how it works makes some sense.  Coenzyme Q-10 is a vitamin-like cofactor found mostly in cellular  structures called mitochondria. Coenzyme Q-10 has an important role in  the biochemical process that results in production of adenosine  triphosphate (ATP). ATP is used by cells as a fuel to produce energy.  Inhibition of ATP production can cause cell death and tissue damage.  Coenzyme Q-10 levels are low in some patients with heart failure.  Researchers think that replacing coenzyme Q-10 might improve cellular  energy production and prevent cell death in people with heart failure.  Coenzyme Q-10 also has antioxidant effects and can prevent oxidative  damage.<sup>12321</sup></p>
<p>There is a lot of controversy about the effectiveness of coenzyme Q-10.  Many cardiologists are skeptical. The reason is that some research  findings are inconsistent. Early clinical studies are mostly positive.  But recent studies are more negative. Most studies show that coenzyme  Q-10 does NOT improve ejection fraction or exercise tolerance.<sup>5090,6037,6038</sup></p>
<p>But coenzyme Q-10 does seem to consistently improve SYMPTOMS&#8230;dyspnea,  edema, etc. There&#8217;s even some evidence that coenzyme Q-10 can improve  quality of life and reduce hospital admission rates.<sup>6407,6408,6409,8909,12170</sup></p>
<p>There isn&#8217;t enough strong evidence to recommend coenzyme Q-10 for all  heart failure patients. But coenzyme Q-10 might be worth a try in some  patients with heart failure, especially those with persistent symptoms.  Consider adding it in patients who still have symptoms despite adequate  treatment with conventional meds. Most clinicians use 100-200 mg,  divided, and given 2-3 times daily.</p>
<table border="1" cellspacing="0" cellpadding="2" width="85%" align="center">
<tbody>
<tr>
<td bgcolor="#fff5cc"><strong>Practice Pearl</strong></td>
</tr>
<tr>
<td>Be careful in patients taking warfarin (<em>Coumadin</em>). Coenzyme Q-10 is chemically similar to vitamin K and might decrease the effectiveness of warfarin.<sup>2128,6048,6199</sup></td>
</tr>
</tbody>
</table>
<p>There&#8217;s a good chance patients will ask about <a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?onlinece=CHF&amp;mono_id=1024&amp;view=m" target="monograph"><strong>taurine</strong></a>. Taurine is an amino acid that is actually increased in the left ventricle of heart failure patients.<sup>9900</sup> Researchers are finding that giving taurine supplements can help some  patients. Taurine can improve cardiac output and decrease symptoms of  heart failure when used for up to a year.<sup>5248,5271,5306,8221</sup></p>
<p>Researchers are still trying to figure out exactly how taurine works.  But it seems to help regulate calcium movement in cardiac muscle cells.  There is also evidence that it might have antioxidant effects, lower  adrenergic stimulation, and decrease blood pressure.<sup>3467,8219,8221,8222</sup> Each of these effects could help heart failure patients.</p>
<p>Most studies have been small and preliminary. As more evidence develops,  taurine may become an important option for heart failure patients. But  for now, there isn&#8217;t enough evidence to recommend it.</td>
</tr>
</tbody>
</table>
</td>
<td width="10"></td>
<td width="130" height="20" valign="top" bgcolor="#fff5cc">
<table border="0" cellspacing="0" cellpadding="0" width="130">
<tbody>
<tr>
<td width="130">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tbody>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="35" /></td>
</tr>
<tr>
<td>
<table cellspacing="0" cellpadding="1" width="122" align="center">
<tbody>
<tr bgcolor="white">
<td colspan="2" align="center"><strong>View brands containing:</strong></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=938" target="monograph">Coenzyme Q-10</a></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="10" /></td>
</tr>
<tr>
<td valign="top">
<table width="96%" align="center">
<tbody>
<tr>
<td colspan="2" height="20" bgcolor="#ffdd77"><span style="color: black;"> <strong> Question #9</strong></span></td>
</tr>
<tr>
<td colspan="2">Which  of the following is most appropriate for a heart failure patient who  continues to have symptoms despite adequate treatment with conventional  medicines?</td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q9A">a. Carnitine</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q9B">b. Coenzyme Q-10</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q9C">c. Hawthorn</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q9D">d. Both A and B</label></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="10" /></td>
</tr>
<tr>
<td valign="top">
<table width="96%" align="center">
<tbody>
<tr>
<td colspan="2" height="20" bgcolor="#ffdd77"><span style="color: black;"> <strong> Question #10</strong></span></td>
</tr>
<tr>
<td colspan="2">Which of the following has preliminary evidence suggesting that it might improve survival in patients with heart failure?</td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q10A">a. Digoxin</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q10B">b. Coenzyme Q-10</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q10C">c. Carnitine</label></td>
</tr>
<tr>
<td width="10%" valign="top"></td>
<td width="90%"><label for="q10D">d. Hawthorn</label></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="10" /></td>
</tr>
<tr>
<td>
<table cellspacing="0" cellpadding="1" width="122" align="center">
<tbody>
<tr bgcolor="white">
<td colspan="2" align="center"><strong>View brands containing:</strong></td>
</tr>
<tr bgcolor="white">
<td width="8" align="center" valign="top">-</td>
<td width="114"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=b&amp;mono_id=1024" target="monograph">Taurine</a></td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="475" valign="top">
<table border="0" cellspacing="0" cellpadding="0" width="475">
<tbody>
<tr>
<td width="475" valign="top"><a name="1339"></a></p>
<table border="0" cellspacing="0" cellpadding="0" width="470">
<tbody>
<tr height="22">
<td width="440" bgcolor="#ffdd77">The Bottom Line</td>
<td width="25" bgcolor="#ffdd77"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceCourse.aspx?s=ND&amp;cs=&amp;pc=07%2D32&amp;cec=1&amp;pm=5#top"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/btn_top-trans.gif" border="0" alt="return to top" /></a></td>
<td></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="475" valign="top">The  thought of using natural medicines for heart failure makes some  clinicians cringe. Heart failure is a serious condition. It requires  serious, proven therapies.</p>
<p>It&#8217;s true; natural medicines are NOT appropriate as primary treatment of  heart failure. But some natural medicines may end up with a place in  therapy&#8230;as adjunctive treatments.</p>
<p>There are a surprising number of beneficial natural medicines for heart  failure. Several could be worth considering as add-on therapy in select  patients&#8230;coenzyme Q-10, carnitine, and L-arginine.</p>
<p>There is growing evidence that some natural medicines may have a real  role in therapy. But they are no substitute for standard treatments.  Make sure patients are not attempting to self-treat heart failure.  Ensure they are getting treatments proven to improve survival&#8230;ACE  inhibitors, beta-blockers, etc. Patients adding on natural meds as  adjunctive treatment should be monitored closely for signs of  improvement or deterioration. These patients should also be watched for  potential interactions.</td>
</tr>
</tbody>
</table>
</td>
<td width="10"></td>
<td width="130" height="20" valign="top" bgcolor="#fff5cc">
<table border="0" cellspacing="0" cellpadding="0" width="130">
<tbody>
<tr>
<td width="130">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tbody>
<tr>
<td><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="5" /></td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td></td>
<td></td>
<td bgcolor="#fff5cc">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tbody>
<tr>
<td height="25"><img src="http://naturaldatabase.therapeuticresearch.com/images/ce/quiz/infocol_btm.gif" alt="" width="100%" height="25" /></td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td>
<table border="0" cellspacing="0" cellpadding="0" width="500" align="center">
<tbody>
<tr>
<td></td>
</tr>
<tr>
<td>
<table border="0" cellspacing="0" cellpadding="4" width="100%" align="center">
<tbody>
<tr>
<td colspan="15" height="30" align="left" valign="middle">Recommendation Chart for Natural Medicines Used for Heart Failure *</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td>
<table border="0" cellspacing="0" cellpadding="0" width="500" align="center">
<tbody>
<tr>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
<td width="64" valign="top" bgcolor="#fff5cc"><img src="http://naturaldatabase.therapeuticresearch.com/images/ce/quiz/r-title.gif" alt="Safety/Effective" width="64" height="30" /></td>
<td height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="63" align="center" valign="top" bgcolor="#fff5cc"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/nd/SearchHelp.aspx?cs=&amp;s=ND&amp;t=10&amp;r=100#ri100" target="SearchHelp">Likely<br />
Safe</a></td>
<td height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="63" align="center" valign="top" bgcolor="#fff5cc"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/nd/SearchHelp.aspx?cs=&amp;s=ND&amp;t=10&amp;r=101#ri101" target="SearchHelp">Possibly<br />
Safe</a></td>
<td height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="63" align="center" valign="top" bgcolor="#fff5cc"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/nd/SearchHelp.aspx?cs=&amp;s=ND&amp;t=10&amp;r=105#ri105" target="SearchHelp">Insufficient<br />
Evidence</a></td>
<td height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="63" align="center" valign="top" bgcolor="#fff5cc"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/nd/SearchHelp.aspx?cs=&amp;s=ND&amp;t=10&amp;r=102#ri102" target="SearchHelp">Possibly<br />
Unsafe</a></td>
<td height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="63" align="center" valign="top" bgcolor="#fff5cc"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/nd/SearchHelp.aspx?cs=&amp;s=ND&amp;t=10&amp;r=103#ri103" target="SearchHelp">Likely<br />
Unsafe</a></td>
<td height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="63" align="center" valign="top" bgcolor="#fff5cc"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/nd/SearchHelp.aspx?cs=&amp;s=ND&amp;t=10&amp;r=104#ri104" target="SearchHelp">Unsafe</a></td>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
</tr>
<tr>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
<td colspan="13" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
</tr>
<tr>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
<td height="30" align="center" valign="top" bgcolor="#fff5cc"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/nd/SearchHelp.aspx?cs=&amp;s=ND&amp;t=10&amp;r=1#ri1" target="SearchHelp">Effective</a></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#33dd33">
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=998" target="monograph">Magnesium</a><br />
(for deficiency)</td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=965" target="monograph">Thiamine</a><br />
(for deficiency)</td>
</tr>
</tbody>
</table>
</td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ffff55"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ffff55"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
</tr>
<tr>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
<td colspan="13" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
</tr>
<tr>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
<td height="30" align="center" valign="top" bgcolor="#fff5cc"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/nd/SearchHelp.aspx?cs=&amp;s=ND&amp;t=10&amp;r=2#ri2" target="SearchHelp">Likely<br />
Effective</a></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#33dd33"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ffff55"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ffff55"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222">
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=287" target="monograph">Digitalis</a></td>
</tr>
</tbody>
</table>
</td>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
</tr>
<tr>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
<td colspan="13" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
</tr>
<tr>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
<td height="30" align="center" valign="top" bgcolor="#fff5cc"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/nd/SearchHelp.aspx?cs=&amp;s=ND&amp;t=10&amp;r=3#ri3" target="SearchHelp">Possibly<br />
Effective</a></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ffff55">
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=938" target="monograph">Coenzyme Q-10</a></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=875" target="monograph">L-arginine</a></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=1026" target="monograph">L-carnitine</a></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=803" target="monograph">Propionyl-L-carnitine</a></td>
</tr>
</tbody>
</table>
</td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ffff55">
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=527" target="monograph">Hawthorn</a></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=1024" target="monograph">Taurine</a></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=811" target="monograph">Terminalia</a></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=873" target="monograph">Creatine</a><br />
(but not advised in CHF)</td>
</tr>
</tbody>
</table>
</td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ffff55"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
</tr>
<tr>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
<td colspan="13" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
</tr>
<tr>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
<td height="30" align="center" valign="top" bgcolor="#fff5cc"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/nd/SearchHelp.aspx?cs=&amp;s=ND&amp;t=10&amp;r=7#ri7" target="SearchHelp">Insufficient<br />
Evidence</a></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ffff55"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ffff55">
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=140" target="monograph">Corn silk</a></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=706" target="monograph">Dandelion</a></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=392" target="monograph">Pomegranate</a></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=664" target="monograph">Stinging nettle</a></td>
</tr>
</tbody>
</table>
</td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ffff55"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222">
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=789" target="monograph">Oleander</a></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=183" target="monograph">Pheasant&#8217;s eye</a></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=743" target="monograph">Squill</a></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="1">
<tbody>
<tr>
<td valign="top">-</td>
<td><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceNDMono.aspx?cs=&amp;s=nd&amp;view=m&amp;mono_id=1163" target="monograph">Star Of Bethlehem</a></td>
</tr>
</tbody>
</table>
</td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
</tr>
<tr>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
<td colspan="13" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
</tr>
<tr>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
<td height="30" align="center" valign="top" bgcolor="#fff5cc"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/nd/SearchHelp.aspx?cs=&amp;s=ND&amp;t=10&amp;r=4#ri4" target="SearchHelp">Possibly<br />
Ineffective</a></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
</tr>
<tr>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
<td colspan="13" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
</tr>
<tr>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
<td height="30" align="center" valign="top" bgcolor="#fff5cc"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/nd/SearchHelp.aspx?cs=&amp;s=ND&amp;t=10&amp;r=5#ri5" target="SearchHelp">Likely<br />
Ineffective</a></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
</tr>
<tr>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
<td colspan="13" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
</tr>
<tr>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
<td height="30" align="center" valign="top" bgcolor="#fff5cc"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/nd/SearchHelp.aspx?cs=&amp;s=ND&amp;t=10&amp;r=6#ri6" target="SearchHelp">Ineffective</a></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="1" height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="1" height="1" /></td>
<td valign="top" bgcolor="#ff2222"></td>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
</tr>
<tr>
<td width="2" height="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
<td colspan="13" height="2" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="2" height="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="0" width="500" align="center">
<tbody>
<tr>
<td>
<table border="0" cellspacing="0" cellpadding="0" width="240">
<tbody>
<tr>
<td colspan="3" height="5"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="5" /></td>
</tr>
<tr>
<td colspan="3" height="20">KEY:</td>
</tr>
<tr>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="2" /></td>
<td height="18" bgcolor="#33dd33">Consider recommending this product.</td>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="2" /></td>
</tr>
<tr>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
<td height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
</tr>
<tr>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
<td height="18" bgcolor="#ffff55">Don&#8217;t recommend using this product.</td>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
</tr>
<tr>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
<td height="1" bgcolor="#000000"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="1" /></td>
<td width="2" height="1" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" height="1" /></td>
</tr>
<tr>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
<td height="18" bgcolor="#ff2222">Recommend against using this product.</td>
<td width="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" width="2" /></td>
</tr>
<tr>
<td colspan="3" height="2" bgcolor="Navy"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/shim.gif" alt="" height="2" /></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td>* These proposed recommendations are based solely on the Safety and Effectiveness 		        Ratings contained in <em>Natural Medicines Comprehensive Database</em>. This assumes use 		        of high-quality, uncontaminated products and the use of typical doses. Keep in 		        mind that some products are never appropriate for some patients due to 		        concomitant disease states, potential drug interactions, or other clinical 		        factors. Use your clinical judgment before recommending any product.</td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="2" cellpadding="2" width="615" align="center">
<tbody>
<tr>
<td colspan="2" align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tbody>
<tr height="22">
<td align="left" bgcolor="#ffdd77"><a name="references"></a>References</td>
<td align="right" bgcolor="#ffdd77"><a rel="nofollow" href="http://naturaldatabase.therapeuticresearch.com/ce/ceCourse.aspx?s=ND&amp;cs=&amp;pc=07%2D32&amp;cec=1&amp;pm=5#top"><img src="http://naturaldatabase.therapeuticresearch.com/images/common/btn_top-trans.gif" border="0" alt="return to top" /></a></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td align="right" valign="top"><strong>110</strong></td>
<td>Lerman A, Burnett JC Jr, Higano ST, et al. Long-term L-arginine improves small-vessel coronary endothelial function in humans.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9626172&amp;dopt=Abstract" target="reference">Circulation 1998;97:2123-8</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>116</strong></td>
<td>Adams  MR, McCredie R, Jessup W, et al. Oral L-arginine improves  endothelium-dependent dilatation and reduces monocyte adhesion to  endothelial cells in young men with coronary artery disease. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9105569&amp;dopt=Abstract" target="reference">Atherosclerosis 1997;129:261-9</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>184</strong></td>
<td>Koshy KM, Griswold E, Schneeberger EE. Interstitial nephritis in a patient taking creatine. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10075534&amp;dopt=Abstract" target="reference">N Engl J Med 1999;340:814-5</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>406</strong></td>
<td>Upton  R, ed. Hawthorn Leaf with Flower: Analytical, quality control, and  therapeutic monograph. Santa Cruz, CA: American Herbal Pharmacopoeia  1999:1-29.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>1284</strong></td>
<td>Shimon  I, Almog S, Vered Z, et al. Improved left ventricular function after  thiamine supplementation in patients with congestive heart failure  receiving long-term furosemide therapy. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7733128&amp;dopt=Abstract" target="reference">Am J Med 1995;98:485-90</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>1285</strong></td>
<td>Pfitzenmeyer  P, Guilland JC, d&#8217;Athis P, et al. Thiamine status of elderly patients  with cardiac failure including the effects of supplementattion. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7960489&amp;dopt=Abstract" target="reference">Int J Vitam Nutr Res 1994;64:113-8</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>1286</strong></td>
<td>Seligmann  H, Halkin H, Rauchfleisch S, et al. Thiamine deficiency in patients  with congestive heart failure receiving long-term furosemide therapy: a  pilot study. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=1867241&amp;dopt=Abstract" target="reference">Am J Med 1991;91:151-5</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>1362</strong></td>
<td>Creager  MA, Gallagher SJ, Girerd XJ, et al.  L-arginine improves  endothelium-dependent vasodilation in hypercholesterolemic humans.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=1401062&amp;dopt=Abstract" target="reference">J Clin Invest 1992;90:1248-53</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>1363</strong></td>
<td>Clarkson  P, Adams MR, Powe AJ, et al.  Oral L-arginine improves  endothelium-dependent dilation in hypercholesterolemic young adults.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8621785&amp;dopt=Abstract" target="reference">J Clin Invest 1996;97:1989-94</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>1439</strong></td>
<td>Siliprandi N, Di Lisa F, Menabo R.  Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=2031869&amp;dopt=Abstract" target="reference">Cardiovasc Drugs Ther 1991;5 Suppl 1:11-5</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>1572</strong></td>
<td>Bartels GL, Remme WJ, Pillay M, et al.  Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=1383625&amp;dopt=Abstract" target="reference">J Cardiovasc Pharmacol 1992;20:157-64</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>1575</strong></td>
<td>Anand  I, Chandrashekhan Y, De Giuli F, et al.  Acute and chronic effects of  propionyl-L-carnitine on the hemodynamics, exercise capacity, and  hormones in patients with congestive heart failure.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9784909&amp;dopt=Abstract" target="reference">Cardiovasc Drugs Ther 1998;12:291-9</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>1582</strong></td>
<td>Caponnetto  S, Canale C, Masperone MA, et al.  Efficacy of L-propionylcarnitine  treatment in patients with left ventricular dysfunction.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7982429&amp;dopt=Abstract" target="reference">Eur Heart J 1994;15:1267-73</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>1583</strong></td>
<td>Mancini  M, Rengo F, Lingetti M, et al.  Controlled study on the therapeutic  efficacy of propionyl-L-carnitine in patients with congestive heart  failure.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=1445476&amp;dopt=Abstract" target="reference">Arzneimittelforschung 1992;42:1101-4</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>2118</strong></td>
<td>Pritchard NR, Kalra PA. Renal dysfunction accompanying oral creatine supplements.  Lancet 1998;351:1252-3.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>2128</strong></td>
<td>Spigset O.  Reduced effect of warfarin caused by ubidecarenone.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7968059&amp;dopt=Abstract" target="reference">Lancet 1994;334:1372-3</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>2504</strong></td>
<td>Bharani A, Ganguly A, Bhargava KD.  Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7649665&amp;dopt=Abstract" target="reference">Int J Cardiol 1995;49:191-9</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>3330</strong></td>
<td>Tenebaum A, Fisman EZ, Motro M.  L-arginine: Rediscovery in progress.  Cardiology 1998;90:153-5.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>3467</strong></td>
<td>Niittynen L, Nurminen ML, Korpela R, et al. Role of arginine, taurine, and homocysteine in cardiovascular diseases. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10574504&amp;dopt=Abstract" target="reference">Ann Med 1999;31:318-26</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>3595</strong></td>
<td>Rector  TS, Bank AJ, Mullen KA, et al. Randomized, double-blind,  placebo-controlled study of supplemental oral L-arginine in patients  with heart failure. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8925582&amp;dopt=Abstract" target="reference">Circulation 1996;93:2135-41</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>3596</strong></td>
<td>Watanabe G, Tomiyama H, Doba N. Effects of oral administration of L-arginine on renal function in patients with heart failure. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10694193&amp;dopt=Abstract" target="reference">J Hypertens 2000;18:229-34</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>3625</strong></td>
<td>Rizos I.  Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10650325&amp;dopt=Abstract" target="reference">Am Heart J 2000;139:S120-3</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>3626</strong></td>
<td>Ghidini O, Azzurro M, Vita G, Sartori G.  Evaluation of the therapeutic efficacy of L-carnitine in congestive heart failure. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=3403101&amp;dopt=Abstract" target="reference">Int J Clin Pharmacol Ther Toxicol 1988;26:217-20</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>4562</strong></td>
<td>Andrews  R, Greenhaff P, Curtis S, et al.  The effect of dietary creatine  supplementation on skeletal muscle metabolism in congestive heart  failure.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9597411&amp;dopt=Abstract" target="reference">Eur Heart J 1998;19:617-22</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>4563</strong></td>
<td>Gordon  A, Hultman E, Kaijser L, et al.  Creatine supplementation in chronic  heart failure increases skeletal muscle creatine phosphate and muscle  performance.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7585833&amp;dopt=Abstract" target="reference">Cardiovasc Res 1995;30:413-8</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>5090</strong></td>
<td>Khatta M, Alexander BS, Krichten CM, et al.  The effect of coenzyme Q10 in patients with congestive heart failure.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10766682&amp;dopt=Abstract" target="reference">Ann Intern Med 2000;132:636-40</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>5248</strong></td>
<td>Azuma J, Sawamura A, Awata N.  Usefulness of taurine in chronic congestive heart failure andits prospective application.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=1538580&amp;dopt=Abstract" target="reference">Jpn Circ J 1992;56:95-9</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>5271</strong></td>
<td>Azuma  J, Sawamura A, Awata N, et al.  Therapeutic effect of taurine in  congestive heart failure: a double-blind crossover trial.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=3888464&amp;dopt=Abstract" target="reference">Clin Cardiol 1985;8:276-82</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>5306</strong></td>
<td>Azuma J, Hasegawa H, Sawamura A, et al.  Therapy of congestive heart failure with orally administered taurine.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=6871923&amp;dopt=Abstract" target="reference">Clin Ther 1983;5:398-408</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>6028</strong></td>
<td>Hambrecht  R, Hilbrich L, Erbs S, et al.  Correction of endothelial dysfunction in  chronic heart failure: additional effects of exercise training and oral  L-arginine supplementation.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10716474&amp;dopt=Abstract" target="reference">J Am Coll Cardiol 2000;35:706-13</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>6037</strong></td>
<td>Watson  PS, Scalia GM, Galbraith A, et al.  Lack of effect of coenzyme Q on  left ventricular function in patients with congestive heart failure.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10334422&amp;dopt=Abstract" target="reference">J Am Coll Cardiol 1999;33:1549-52</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>6038</strong></td>
<td>Permanetter  B, Rossy W, Klein G, et al.  Ubiquinone (coenzyme Q10) in the long-term  treatment of idiopathic dilated cardiomyopathy.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=1464342&amp;dopt=Abstract" target="reference">Eur Heart J 1992;13:1528-33</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>6048</strong></td>
<td>Heck AM, DeWitt BA, Lukes AL.  Potential interactions between alternative therapies and warfarin.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10902065&amp;dopt=Abstract" target="reference">Am J Health Syst Pharm 2000;57:1221-7</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>6199</strong></td>
<td>Landbo C, Almdal TP.  [Interaction between warfarin and coenzyme Q10].  [Article in Danish]. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9621803&amp;dopt=Abstract" target="reference">Ugeskr Laeger 1998;160:3226-7</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>6407</strong></td>
<td>Morisco  C, Trimarco B, Condorelli M.  Effect of coenzyme Q10 therapy in  patients with congestive heart failure: A long-term, multicenter,  randomized study. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8241697&amp;dopt=Abstract" target="reference">Clin Investig 1993;71:S134-6</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>6408</strong></td>
<td>Hofman-Bang C, Rehnqvist N, Swedberg K, et al.  Coenzyme Q10 as an adjunctive treatment of congestive heart failure.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9420639&amp;dopt=Abstract" target="reference">J Card Fail 1995;1:101-7</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>6409</strong></td>
<td>Baggio  E, Gandini R, Plauncher AC, et al.  Italian multicenter study on the  safety and efficacy of coenzyme Q10 as adjunctive therapy in heart  failure. CoQ10 Drug Surveillance Investigators. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7752841&amp;dopt=Abstract" target="reference">Mol Aspects Med 1994;15 Suppl:S287-94</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>6430</strong></td>
<td>Anderson PO, Knoben JE.  Handbook of Clinical Drug Data. 8th ed. Stamford, CT: Appleton &amp; Lange, 1997.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>7813</strong></td>
<td>Kanaya  Y, Nakamura M, Kobayashi N, Hiramori K. Effects of L-arginine on lower  limb vasodilator reserve and exercise capacity in patients with chronic  heart failure. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10212170&amp;dopt=Abstract" target="reference"> Heart 1999;81:512-7</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>7820</strong></td>
<td>Wu G, Meininger CJ. Arginine nutrition and cardiovascular function.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11053497&amp;dopt=Abstract" target="reference">J Nutr 2000;130:2626-9</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>8014</strong></td>
<td>Chin-Dusting  JP, Kaye DM, Lefkovits J, et al. Dietary supplementation with  L-arginine fails to restore endothelial function in forearm resistance  arteries of patients with severe heart failure. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8609344&amp;dopt=Abstract" target="reference">J Am Coll Cardiol 1996;27:1207-13</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>8219</strong></td>
<td>Paasonen  MK, Penttila O, Himberg JJ, et al.  Platelet taurine in patients with  arterial hypertension, myocardial failure or infarction. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=6935947&amp;dopt=Abstract" target="reference">Acta Med Scand Suppl 1980;642:79-84</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>8221</strong></td>
<td>Azuma J.  Long-term effect of taurine in congestive heart failure: Preliminary report. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7887286&amp;dopt=Abstract" target="reference"> Adv Exp Med Biol 1994;359:425-33</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>8222</strong></td>
<td>Azuma J, Takihara K, Awata N, et al.  Taurine and failing heart: experimental and clinical aspects. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=4059214&amp;dopt=Abstract" target="reference">Prog Clin Biol Res 1985;179:195-213</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>8279</strong></td>
<td>Schmidt  U, Kuhn U, Ploch M, Hubner WD.  Efficacy of the Hawthorne (Crataegus)  Preparation LI 132 in 78 patients with chronic congestive heart failure  defined as NYHA functional class II.  Phytomedicine 1994;1:17-24.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>8280</strong></td>
<td>Zapfe jun G.  Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11515715&amp;dopt=Abstract" target="reference">Phytomedicine 2001;8:262-6</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>8310</strong></td>
<td>Aviram  M, Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin  converting enzyme activity and reduces systolic blood pressure. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11500191&amp;dopt=Abstract" target="reference">Atherosclerosis 2001;158:195-8</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>8909</strong></td>
<td>Soja AM, Mortensen SA. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9266518&amp;dopt=Abstract" target="reference">Mol Aspects Med  1997;18:S159-68</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>9613</strong></td>
<td>Ryan MP.  Diuretics and potassium/magnesium depletion: directions for treatment. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=3551599&amp;dopt=Abstract" target="reference">Am J Med 1987;82:38-47.</a></td>
</tr>
<tr>
<td align="right" valign="top"><strong>9614</strong></td>
<td>Hollifield JW.  Magnesium depletion, diuretics, and arrhythmias. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=2436474&amp;dopt=Abstract" target="reference">Am J Med 1987;82:30-7.</a></td>
</tr>
<tr>
<td align="right" valign="top"><strong>9900</strong></td>
<td>Huxtable R, Bressler R. Elevation of taurine in human congestive heart failure. Life Sci 1974;14:1353-9.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>10144</strong></td>
<td>Pittler MH, Schmidt K, Ernst E.  Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12798455&amp;dopt=Abstract" target="reference">Am J Med 2003;114:665-74.</a></td>
</tr>
<tr>
<td align="right" valign="top"><strong>10506</strong></td>
<td>Levy WC, Soine LA, Huth MM, Fishbein DP.  Thiamine deficiency in heart failure (letter). Am J Med 1992;93:705-6.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>10507</strong></td>
<td>Leslie  D, Gheorghiade M.  Is there a role for thiamine supplementation in the  management of heart failure. Am Heart J 1996;131:1248-50.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>10508</strong></td>
<td>Saif MW.  Is there a role for thiamine in the management of congestive heart failure? (letter) South Med J 2003;96:114-5.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>11449</strong></td>
<td>Degenring  FH, Suter A, Weber M, Saller R.  A randomised double blind placebo  controlled clinical trial of a standardised extract of fresh Crataegus  berries (Crataegisan) in the treatment of patients with congestive heart  failure NYHA II. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12833999&amp;dopt=Abstract" target="reference">Phytomedicine 2003;10:363-9</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>11450</strong></td>
<td>Schwinger  RH, Pietsch M, Frank K, Brixius K.  Crataegus special extract WS 1442  increases force of contraction in human myocardium cAMP-independently.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10813370&amp;dopt=Abstract" target="reference">J Cardiovasc Pharmacol 2000;35:700-7</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>12170</strong></td>
<td>Berman  M, Erman A, Ben-Gal T, et al.  Coenzyme Q10 in patients with end-stage  heart failure awaiting cardiac transplantation: a randomized,  placebo-controlled study.  <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15188947&amp;dopt=Abstract" target="reference">Clin Cardiol 2004;27:295–9</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>12316</strong></td>
<td>Sonnenblick E. Detecting and treating heart failure: An update on strategies. www.ConsultantLive.com (Accessed 24 January 2001).</td>
</tr>
<tr>
<td align="right" valign="top"><strong>12317</strong></td>
<td>Skrabal  M, Stading J, Behmer-Miller K, et al. Advances in the treatment of  congestive heart failure: New approaches for an old disease. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10907969&amp;dopt=Abstract" target="reference">Pharmacotherapy 2000;20:787-804</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>12318</strong></td>
<td>Pharmacotherapy  Self-Assessment Program. Module 1: Cardiology. 3rd Ed. Kansas City, MO:  American College of Clinical Pharmacy, 1998.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>12319</strong></td>
<td>Adams  KF, Baughman KL, Konstam MA, et al. Heart failure society guidelines: A  model of consensus and excellence. Pharmacotherapy 2000;20:495-522.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>12320</strong></td>
<td>Valsartan for heart failure. Pharmacist&#8217;s Letter / Prescriber&#8217;s Letter 2000;17(1):170104.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>12321</strong></td>
<td>Pitt  B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity  and mortality in patients with severe heart failure. Randomized  Aldactone Evaluation Study Investigators. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10471456&amp;dopt=Abstract" target="reference">N Engl J Med 1999;341:709-17</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>12322</strong></td>
<td>McMurray JJ, O&#8217;Meara E. Treatment of heart failure with spironolactone&#8211;trial and tribulations. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15295043&amp;dopt=Abstract" target="reference">N Engl J Med 2004;351:526-8</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>12323</strong></td>
<td>El-Aroussy W, et al. Plasma carnitine levels as a marker of impaired ventricular function. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11129956&amp;dopt=Abstract" target="reference">Mol Cell Biochem 2000;213:37-41</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>15331</strong></td>
<td>Vogelsang A. Ornithogalum umbellatum in the treatment of congestive heart failure: progress report. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=13926446&amp;dopt=Abstract" target="reference">J Am Geriatr Soc 1961;9:1096-9</a>.</td>
</tr>
<tr>
<td align="right" valign="top"><strong>15332</strong></td>
<td>Vogelsang A. Clinical trial of Ornithogalum umbellatum on the human heart; preliminary report. <a rel="nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=13240604&amp;dopt=Abstract" target="reference">Can Med Assoc J 1955;73:295-6</a>.</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/10/11/natural-medicines-in-the-clinical-management-of-heart-failure/feed/</wfw:commentRss>
		<slash:comments>6</slash:comments>
		</item>
		<item>
		<title>Depression Leads to Protein Linked to Heart Disease</title>
		<link>http://www.epatienthealthcare.com/blog/2009/12/10/depression-leads-to-protein-linked-to-heart-disease/</link>
		<comments>http://www.epatienthealthcare.com/blog/2009/12/10/depression-leads-to-protein-linked-to-heart-disease/#comments</comments>
		<pubDate>Thu, 10 Dec 2009 06:39:23 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Herbs]]></category>
		<category><![CDATA[Human Behavior]]></category>
		<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Medical Studies]]></category>
		<category><![CDATA[Vitamins - Supplements]]></category>
		<category><![CDATA[cause of heart disease]]></category>
		<category><![CDATA[cholesterol]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[diet]]></category>
		<category><![CDATA[E Patient]]></category>
		<category><![CDATA[E-Care]]></category>
		<category><![CDATA[fats]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[free-radical]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[heart]]></category>
		<category><![CDATA[heart disease]]></category>
		<category><![CDATA[processed food]]></category>
		<category><![CDATA[thyroid]]></category>
		<category><![CDATA[treatment of heart disease]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/2009/12/10/depression-leads-to-protein-linked-to-heart-disease/</guid>
		<description><![CDATA[BLOOMINGTON &#8211; Depression leads to elevated inflammatory proteins in the human body, according to researchers at Indiana University-Purdue University Indianapolis. Led by Dr. Jesse Stewart, researchers found that depressive symptoms are associated with increases over time in interleukin-6, an inflammatory protein that predicts cardiovascular events. On the other hand, levels of interleukin-6 were not linked [...]]]></description>
			<content:encoded><![CDATA[<p><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ProgId" content="Word.Document" /><meta name="Generator" content="Microsoft Word 12" /><meta name="Originator" content="Microsoft Word 12" /></p>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml" rel="File-List" /><o:smarttagtype namespaceuri="urn:schemas:contacts" name="title"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas:contacts" name="Sn"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas:contacts" name="GivenName"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="PersonName"></o:smarttagtype>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx" rel="themeData" />
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml" rel="colorSchemeMapping" /><!--[if gte mso 9]><xml>  <w:WordDocument>   <w:View>Normal</w:View>   <w:Zoom>0</w:Zoom>   <w:TrackMoves/>   <w:TrackFormatting/>   <w:PunctuationKerning/>   <w:ValidateAgainstSchemas/>   <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>   <w:IgnoreMixedContent>false</w:IgnoreMixedContent>   <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>   <w:DoNotPromoteQF/>   <w:LidThemeOther>EN-US</w:LidThemeOther>   <w:LidThemeAsian>X-NONE</w:LidThemeAsian>   <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>   <w:Compatibility>    <w:BreakWrappedTables/>    <w:SnapToGridInCell/>    <w:WrapTextWithPunct/>    <w:UseAsianBreakRules/>    <w:DontGrowAutofit/>    <w:SplitPgBreakAndParaMark/>    <w:DontVertAlignCellWithSp/>    <w:DontBreakConstrainedForcedTables/>    <w:DontVertAlignInTxbx/>    <w:Word11KerningPairs/>    <w:CachedColBalance/>   </w:Compatibility>   <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>   <m:mathPr>    <m:mathFont m:val="Cambria Math"/>    <m:brkBin m:val="before"/>    <m:brkBinSub m:val="&#45;-"/>    <m:smallFrac m:val="off"/>    <m:dispDef/>    <m:lMargin m:val="0"/>    <m:rMargin m:val="0"/>    <m:defJc m:val="centerGroup"/>    <m:wrapIndent m:val="1440"/>    <m:intLim m:val="subSup"/>    <m:naryLim m:val="undOvr"/>   </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml>  <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"   DefSemiHidden="true" DefQFormat="false" DefPriority="99"   LatentStyleCount="267">   <w:LsdException Locked="false" Priority="0" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Normal"/>   <w:LsdException Locked="false" Priority="9" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>   <w:LsdException Locked="false" Priority="39" Name="toc 1"/>   <w:LsdException Locked="false" Priority="39" Name="toc 2"/>   <w:LsdException Locked="false" Priority="39" Name="toc 3"/>   <w:LsdException Locked="false" Priority="39" Name="toc 4"/>   <w:LsdException Locked="false" Priority="39" Name="toc 5"/>   <w:LsdException Locked="false" Priority="39" Name="toc 6"/>   <w:LsdException Locked="false" Priority="39" Name="toc 7"/>   <w:LsdException Locked="false" Priority="39" Name="toc 8"/>   <w:LsdException Locked="false" Priority="39" Name="toc 9"/>   <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>   <w:LsdException Locked="false" Priority="10" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Title"/>   <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>   <w:LsdException Locked="false" Priority="11" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>   <w:LsdException Locked="false" Priority="22" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Strong"/>   <w:LsdException Locked="false" Priority="20" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>   <w:LsdException Locked="false" Priority="59" SemiHidden="false"    UnhideWhenUsed="false" Name="Table Grid"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>   <w:LsdException Locked="false" Priority="1" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 1"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 1"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 1"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>   <w:LsdException Locked="false" Priority="34" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>   <w:LsdException Locked="false" Priority="29" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Quote"/>   <w:LsdException Locked="false" Priority="30" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 1"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 1"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 2"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 2"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 2"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 2"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 2"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 3"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 3"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 3"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 3"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 3"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 4"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 4"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 4"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 4"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 4"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 5"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 5"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 5"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 5"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 5"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 6"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 6"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 6"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 6"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 6"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>   <w:LsdException Locked="false" Priority="19" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>   <w:LsdException Locked="false" Priority="21" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>   <w:LsdException Locked="false" Priority="31" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>   <w:LsdException Locked="false" Priority="32" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>   <w:LsdException Locked="false" Priority="33" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>   <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>   <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>  </w:LatentStyles> </xml><![endif]--><!--[if !mso]><object  classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></object><br />
<style> st1\:*{behavior:url(#ieooui) }st2\:*{behavior:url(#ieooui) } </style>
<p> <![endif]--><br />
<style> <!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:roman; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin-top:0in; 	margin-right:0in; 	margin-bottom:10.0pt; 	margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.25in 1.0in 1.25in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --> </style>
<p><!--[if gte mso 10]><br />
<style>  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;} </style>
<p> <![endif]--></p>
<p class="MsoNormal">BLOOMINGTON &#8211; Depression leads to elevated inflammatory proteins in the human body, according to researchers at Indiana University-Purdue University Indianapolis.<o:p></o:p></p>
<p class="MsoNormal">Led by <st2:personname w:st="on"><st1:title w:st="on">Dr.</st1:title>  <st1:givenname w:st="on">Jesse</st1:givenname> <st1:sn w:st="on">Stewart</st1:sn></st2:personname>, researchers found that depressive symptoms are associated with increases over time in interleukin-6, an inflammatory protein that predicts cardiovascular events.<o:p></o:p></p>
<p class="MsoNormal">On the other hand, levels of interleukin-6 were not linked to subsequent increases in depressive symptoms.<o:p></o:p></p>
<p class="MsoNormal">The new study is the first to examine both directions of the depression-inflammation connection and to measure the physical symptoms of depression, such as fatigue and sleep disturbance, in addition to the cognitive-emotional symptoms, such as pessimism and sadness.<o:p></o:p></p>
<p class="MsoNormal">While many previous studies have linked depression to increased inflammatory protein levels measured at the same time, but they couldn’t speak to which is the cause and which is the effect.<o:p></o:p></p>
<p class="MsoNormal">“There is two-way communication between the brain and the immune system, so we had to determine whether activation of the body’s immune system sent a signal to the brain to affect mood and behavior or whether the depression activated the immune system,” said <st2:personname w:st="on"><st1:title w:st="on">Dr.</st1:title> <st1:sn w:st="on">Stewart</st1:sn></st2:personname>.<o:p></o:p></p>
<p class="MsoNormal">The participants in the study consisted of 263 healthy men and women aged 50-70 years at the start of the study.<o:p></o:p></p>
<p class="MsoNormal">They were tested at baseline and again six years later to determine their levels of depressive symptoms and interleukin-6.<o:p></o:p></p>
<p class="MsoNormal">Levels of C-reactive protein, another inflammatory protein, were also measured but were not related to depression.<o:p></o:p></p>
<p class="MsoNormal"><st1:givenname w:st="on">Stewart</st1:givenname> said that the strength of the association of depression with future heart disease is similar to that of traditional risk factors like smoking, high blood pressure and elevated cholesterol.<o:p></o:p></p>
<p class="MsoNormal">“Promotion of inflammation may be one pathway through which depression may ‘get under the skin’ to negatively influence cardiovascular health. The link to cardiovascular disease demonstrates that there may be physical as well as mental health reasons to treat depression,” said <st1:givenname w:st="on">Stewart</st1:givenname>.<o:p></o:p></p>
<p class="MsoNormal">The study has been published in the latest issue of the journal Brain, Behavior and Immunity.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2009/12/10/depression-leads-to-protein-linked-to-heart-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Large Thighs May Protect Heart</title>
		<link>http://www.epatienthealthcare.com/blog/2009/11/03/large-thighs-may-protect-heart/</link>
		<comments>http://www.epatienthealthcare.com/blog/2009/11/03/large-thighs-may-protect-heart/#comments</comments>
		<pubDate>Tue, 03 Nov 2009 21:49:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Medical Studies]]></category>
		<category><![CDATA[Odd Medical Practices]]></category>
		<category><![CDATA[Weight Management]]></category>
		<category><![CDATA[cause of heart disease]]></category>
		<category><![CDATA[cholesterol]]></category>
		<category><![CDATA[diet]]></category>
		<category><![CDATA[fat thighs]]></category>
		<category><![CDATA[fats]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[free-radical]]></category>
		<category><![CDATA[GE E-Care]]></category>
		<category><![CDATA[heart]]></category>
		<category><![CDATA[heart disease]]></category>
		<category><![CDATA[insulin]]></category>
		<category><![CDATA[processed food]]></category>
		<category><![CDATA[smoking]]></category>
		<category><![CDATA[thyroid]]></category>
		<category><![CDATA[treatment of heart disease]]></category>
		<category><![CDATA[USTM Patients]]></category>
		<category><![CDATA[Vitamins - Supplements]]></category>

		<guid isPermaLink="false">http://www.gembpatients.com/blog/2009/11/03/large-thighs-may-protect-heart/</guid>
		<description><![CDATA[COPENHAGEN &#8211; Men and women with thighs over 60cm (23.6in) in circumference have a lower risk of heart disease and early death, a study of 3,000 people suggests. The relationship remains even when body fat, smoking and blood cholesterol are taken into account, a Danish team says. Those with narrow thighs may not have enough [...]]]></description>
			<content:encoded><![CDATA[<p><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ProgId" content="Word.Document" /><meta name="Generator" content="Microsoft Word 12" /><meta name="Originator" content="Microsoft Word 12" /></p>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml" rel="File-List" /><o:smarttagtype namespaceuri="urn:schemas:contacts" name="title"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas:contacts" name="Sn"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas:contacts" name="GivenName"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="PersonName"></o:smarttagtype>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx" rel="themeData" />
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml" rel="colorSchemeMapping" /><!--[if gte mso 9]><xml>  <w:WordDocument>   <w:View>Normal</w:View>   <w:Zoom>0</w:Zoom>   <w:TrackMoves/>   <w:TrackFormatting/>   <w:PunctuationKerning/>   <w:ValidateAgainstSchemas/>   <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>   <w:IgnoreMixedContent>false</w:IgnoreMixedContent>   <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>   <w:DoNotPromoteQF/>   <w:LidThemeOther>EN-US</w:LidThemeOther>   <w:LidThemeAsian>X-NONE</w:LidThemeAsian>   <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>   <w:Compatibility>    <w:BreakWrappedTables/>    <w:SnapToGridInCell/>    <w:WrapTextWithPunct/>    <w:UseAsianBreakRules/>    <w:DontGrowAutofit/>    <w:SplitPgBreakAndParaMark/>    <w:DontVertAlignCellWithSp/>    <w:DontBreakConstrainedForcedTables/>    <w:DontVertAlignInTxbx/>    <w:Word11KerningPairs/>    <w:CachedColBalance/>   </w:Compatibility>   <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>   <m:mathPr>    <m:mathFont m:val="Cambria Math"/>    <m:brkBin m:val="before"/>    <m:brkBinSub m:val="&#45;-"/>    <m:smallFrac m:val="off"/>    <m:dispDef/>    <m:lMargin m:val="0"/>    <m:rMargin m:val="0"/>    <m:defJc m:val="centerGroup"/>    <m:wrapIndent m:val="1440"/>    <m:intLim m:val="subSup"/>    <m:naryLim m:val="undOvr"/>   </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml>  <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"   DefSemiHidden="true" DefQFormat="false" DefPriority="99"   LatentStyleCount="267">   <w:LsdException Locked="false" Priority="0" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Normal"/>   <w:LsdException Locked="false" Priority="9" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>   <w:LsdException Locked="false" Priority="39" Name="toc 1"/>   <w:LsdException Locked="false" Priority="39" Name="toc 2"/>   <w:LsdException Locked="false" Priority="39" Name="toc 3"/>   <w:LsdException Locked="false" Priority="39" Name="toc 4"/>   <w:LsdException Locked="false" Priority="39" Name="toc 5"/>   <w:LsdException Locked="false" Priority="39" Name="toc 6"/>   <w:LsdException Locked="false" Priority="39" Name="toc 7"/>   <w:LsdException Locked="false" Priority="39" Name="toc 8"/>   <w:LsdException Locked="false" Priority="39" Name="toc 9"/>   <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>   <w:LsdException Locked="false" Priority="10" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Title"/>   <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>   <w:LsdException Locked="false" Priority="11" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>   <w:LsdException Locked="false" Priority="22" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Strong"/>   <w:LsdException Locked="false" Priority="20" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>   <w:LsdException Locked="false" Priority="59" SemiHidden="false"    UnhideWhenUsed="false" Name="Table Grid"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>   <w:LsdException Locked="false" Priority="1" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 1"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 1"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 1"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>   <w:LsdException Locked="false" Priority="34" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>   <w:LsdException Locked="false" Priority="29" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Quote"/>   <w:LsdException Locked="false" Priority="30" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 1"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 1"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 2"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 2"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 2"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 2"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 2"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 3"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 3"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 3"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 3"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 3"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 4"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 4"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 4"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 4"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 4"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 5"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 5"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 5"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 5"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 5"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 6"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 6"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 6"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 6"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 6"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>   <w:LsdException Locked="false" Priority="19" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>   <w:LsdException Locked="false" Priority="21" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>   <w:LsdException Locked="false" Priority="31" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>   <w:LsdException Locked="false" Priority="32" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>   <w:LsdException Locked="false" Priority="33" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>   <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>   <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>  </w:LatentStyles> </xml><![endif]--><!--[if !mso]><object  classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></object><br />
<style> st1\:*{behavior:url(#ieooui) }st2\:*{behavior:url(#ieooui) } </style>
<p> <![endif]--><br />
<style> <!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:roman; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin-top:0in; 	margin-right:0in; 	margin-bottom:10.0pt; 	margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.25in 1.0in 1.25in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --> </style>
<p><!--[if gte mso 10]><br />
<style>  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;} </style>
<p> <![endif]--></p>
<p class="MsoNormal">COPENHAGEN &#8211; Men and women with thighs over 60cm (23.6in) in circumference have a lower risk of heart disease and early death, a study of 3,000 people suggests.<o:p></o:p></p>
<p class="MsoNormal">The relationship remains even when body fat, smoking and blood cholesterol are taken into account, a Danish team says.<o:p></o:p></p>
<p class="MsoNormal">Those with narrow thighs may not have enough muscle mass to deal with insulin properly, raising the risk of diabetes and, in turn, heart disease, they say.<o:p></o:p></p>
<p class="MsoNormal">Experts cautioned that the research needed corroborating.<o:p></o:p></p>
<p class="MsoNormal">Some said it was too early to change current advice on eating and exercise for heart health, but the researchers said thigh size could be used as a marker for at-risk patients.<o:p></o:p></p>
<p class="MsoNormal">The study, published in the British Medical Journal, followed men and women in Denmark for more than 10 years.<o:p></o:p></p>
<p class="MsoNormal">They were measured for height, weight and thigh, hip and waist circumference and their overall percentage of body fat was calculated.<o:p></o:p></p>
<p class="MsoNormal">It&#8217;s a very simple, very crude measure but it seems to have an individual effect. And it may be a way for doctors to assess risk<o:p></o:p></p>
<p class="MsoNormal">The thigh measurement was taken just below the gluteal fold, which is the crease caused by your buttocks.<o:p></o:p></p>
<p class="MsoNormal">Researchers also looked at the activity levels of the participants, whether they smoked, their blood pressure and cholesterol levels.<o:p></o:p></p>
<p class="MsoNormal">They then monitored incidence of heart disease over 10 years and death rates over 12-and-a-half years.<o:p></o:p></p>
<p class="MsoNormal">During this time, 257 men and 155 women died, 263 men and 140 women developed cardiovascular disease and 103 men and 34 women suffered from heart disease.<o:p></o:p></p>
<p class="MsoNormal">The team at the Copenhagen University Hospital found that those with the smallest thighs &#8211; below 55cm &#8211; had twice the risk of early death or serious health problems.<o:p></o:p></p>
<p class="MsoNormal"><st2:personname w:st="on"><st1:title w:st="on">Professor</st1:title>  <st1:givenname w:st="on">Berit</st1:givenname> <st1:sn w:st="on">Heitmann</st1:sn></st2:personname>, who led the research, said: &#8220;The increased risk was independent of abdominal and general obesity and lifestyle and cardiovascular risk factors such as blood pressure.<o:p></o:p></p>
<p class="MsoNormal">&#8220;Additionally we found that the risk was more highly related to thigh circumference than to waist circumference.</p>
<p class="MsoNormal">&#8220;It&#8217;s a very simple, very crude measure but it seems to have an individual effect. And it may be a way for doctors to assess risk.<o:p></o:p></p>
<p class="MsoNormal">&#8220;The nice thing is that if you have a small thigh you can do something about it through exercise.&#8221;<o:p></o:p></p>
<p class="MsoNormal">Previous studies have suggested that a waist circumference of over 35in (88.9cm) for a woman and 40in (101.6cm) for a man indicated a high risk of developing diabetes and heart disease.<o:p></o:p></p>
<p class="MsoNormal"><st2:personname w:st="on"><st1:title w:st="on">Professor</st1:title>  <st1:sn w:st="on">Heitmann</st1:sn></st2:personname>&#8216;s team says the risk of narrow thighs could be associated with too little muscle mass.<o:p></o:p></p>
<p class="MsoNormal">They say this can lead to the body not responding to insulin properly, increasing the risk of type 2 diabetes and, in the long-run, heart disease.<o:p></o:p></p>
<p class="MsoNormal">Too little fat can also lead to adverse changes in the way the body breaks down food.<o:p></o:p></p>
<p class="MsoNormal">British Heart Foundation senior cardiac nurse <st2:personname w:st="on"><st1:givenname w:st="on">Judy</st1:givenname> <st1:sn w:st="on">O&#8217;Sullivan</st1:sn></st2:personname> said: &#8220;There is insufficient evidence to confirm that a low thigh circumference affects a person&#8217;s risk of developing cardiovascular disease.<o:p></o:p></p>
<p class="MsoNormal">&#8220;However, low muscle mass is associated with low levels of physical activity which is an established risk factor for developing heart disease.&#8221;<o:p></o:p></p>
<p class="MsoNormal">Tam Fry, of the National Obesity Forum, agreed that the research needed further corroboration, saying: &#8220;This is a very interesting and slightly counter-intuitive piece of work but it has to be respected because of the numbers looked at and the duration of the research.<o:p></o:p></p>
<p class="MsoNormal">&#8220;<em>This must be great news for people with larger thighs</em>. What I find fascinating is that researchers are now going back to the drawing board and looking for every possible way of mitigating obesity.&#8221;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2009/11/03/large-thighs-may-protect-heart/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comprehensive Eating Disorders Dictionary for Parents Launched by F.E.A.S.T.</title>
		<link>http://www.epatienthealthcare.com/blog/2009/10/26/comprehensive-eating-disorders-dictionary-for-parents-launched-by-feast/</link>
		<comments>http://www.epatienthealthcare.com/blog/2009/10/26/comprehensive-eating-disorders-dictionary-for-parents-launched-by-feast/#comments</comments>
		<pubDate>Tue, 27 Oct 2009 00:47:54 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Weight Management]]></category>
		<category><![CDATA[cause of heart disease]]></category>
		<category><![CDATA[cholesterol]]></category>
		<category><![CDATA[diet]]></category>
		<category><![CDATA[fats]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[free-radical]]></category>
		<category><![CDATA[GE E-Care]]></category>
		<category><![CDATA[heart]]></category>
		<category><![CDATA[heart disease]]></category>
		<category><![CDATA[processed food]]></category>
		<category><![CDATA[thyroid]]></category>
		<category><![CDATA[treatment of heart disease]]></category>
		<category><![CDATA[USTM Patients]]></category>
		<category><![CDATA[Vitamins - Supplements]]></category>

		<guid isPermaLink="false">http://www.gembpatients.com/blog/2009/10/26/comprehensive-eating-disorders-dictionary-for-parents-launched-by-feast/</guid>
		<description><![CDATA[Comprehensive Eating Disorders Dictionary for Parents Launched by F.E.A.S.T. F.E.A.S.T. has launched a free online dictionary for parents that explains the complex terms and concepts used in the diagnosis and treatment of eating disorders, eating disturbances and a wide range of co-existing conditions.  An international eating disorders organization has launched the world’s first comprehensive dictionary [...]]]></description>
			<content:encoded><![CDATA[<p><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ProgId" content="Word.Document" /><meta name="Generator" content="Microsoft Word 12" /><meta name="Originator" content="Microsoft Word 12" /></p>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml" rel="File-List" /><o:smarttagtype namespaceuri="urn:schemas:contacts" name="title"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="PersonName"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas:contacts" name="Sn"></o:smarttagtype>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx" rel="themeData" />
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml" rel="colorSchemeMapping" /><!--[if gte mso 9]><xml>  <w:WordDocument>   <w:View>Normal</w:View>   <w:Zoom>0</w:Zoom>   <w:TrackMoves/>   <w:TrackFormatting/>   <w:PunctuationKerning/>   <w:ValidateAgainstSchemas/>   <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>   <w:IgnoreMixedContent>false</w:IgnoreMixedContent>   <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>   <w:DoNotPromoteQF/>   <w:LidThemeOther>EN-US</w:LidThemeOther>   <w:LidThemeAsian>X-NONE</w:LidThemeAsian>   <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>   <w:Compatibility>    <w:BreakWrappedTables/>    <w:SnapToGridInCell/>    <w:WrapTextWithPunct/>    <w:UseAsianBreakRules/>    <w:DontGrowAutofit/>    <w:SplitPgBreakAndParaMark/>    <w:DontVertAlignCellWithSp/>    <w:DontBreakConstrainedForcedTables/>    <w:DontVertAlignInTxbx/>    <w:Word11KerningPairs/>    <w:CachedColBalance/>   </w:Compatibility>   <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>   <m:mathPr>    <m:mathFont m:val="Cambria Math"/>    <m:brkBin m:val="before"/>    <m:brkBinSub m:val="&#45;-"/>    <m:smallFrac m:val="off"/>    <m:dispDef/>    <m:lMargin m:val="0"/>    <m:rMargin m:val="0"/>    <m:defJc m:val="centerGroup"/>    <m:wrapIndent m:val="1440"/>    <m:intLim m:val="subSup"/>    <m:naryLim m:val="undOvr"/>   </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml>  <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"   DefSemiHidden="true" DefQFormat="false" DefPriority="99"   LatentStyleCount="267">   <w:LsdException Locked="false" Priority="0" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Normal"/>   <w:LsdException Locked="false" Priority="9" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>   <w:LsdException Locked="false" Priority="39" Name="toc 1"/>   <w:LsdException Locked="false" Priority="39" Name="toc 2"/>   <w:LsdException Locked="false" Priority="39" Name="toc 3"/>   <w:LsdException Locked="false" Priority="39" Name="toc 4"/>   <w:LsdException Locked="false" Priority="39" Name="toc 5"/>   <w:LsdException Locked="false" Priority="39" Name="toc 6"/>   <w:LsdException Locked="false" Priority="39" Name="toc 7"/>   <w:LsdException Locked="false" Priority="39" Name="toc 8"/>   <w:LsdException Locked="false" Priority="39" Name="toc 9"/>   <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>   <w:LsdException Locked="false" Priority="10" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Title"/>   <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>   <w:LsdException Locked="false" Priority="11" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>   <w:LsdException Locked="false" Priority="22" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Strong"/>   <w:LsdException Locked="false" Priority="20" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>   <w:LsdException Locked="false" Priority="59" SemiHidden="false"    UnhideWhenUsed="false" Name="Table Grid"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>   <w:LsdException Locked="false" Priority="1" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 1"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 1"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 1"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>   <w:LsdException Locked="false" Priority="34" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>   <w:LsdException Locked="false" Priority="29" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Quote"/>   <w:LsdException Locked="false" Priority="30" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 1"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 1"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 2"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 2"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 2"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 2"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 2"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 3"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 3"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 3"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 3"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 3"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 4"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 4"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 4"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 4"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 4"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 5"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 5"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 5"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 5"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 5"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 6"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 6"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 6"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 6"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 6"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>   <w:LsdException Locked="false" Priority="19" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>   <w:LsdException Locked="false" Priority="21" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>   <w:LsdException Locked="false" Priority="31" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>   <w:LsdException Locked="false" Priority="32" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>   <w:LsdException Locked="false" Priority="33" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>   <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>   <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>  </w:LatentStyles> </xml><![endif]--><!--[if !mso]><object  classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></object><br />
<style> st1\:*{behavior:url(#ieooui) }st2\:*{behavior:url(#ieooui) } </style>
<p> <![endif]--><br />
<style> <!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:1; 	mso-generic-font-family:roman; 	mso-font-format:other; 	mso-font-pitch:variable; 	mso-font-signature:0 0 0 0 0 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin-top:0in; 	margin-right:0in; 	margin-bottom:10.0pt; 	margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.25in 1.0in 1.25in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --> </style>
<p><!--[if gte mso 10]><br />
<style>  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:"Times New Roman"; 	mso-fareast-theme-font:minor-fareast; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;} </style>
<p> <![endif]--></p>
<p class="MsoNormal"><strong><span style="font-size: 14pt; line-height: 115%">Comprehensive Eating Disorders Dictionary for Parents Launched by F.E.A.S.T.<o:p></o:p></span></strong></p>
<p class="MsoNormal">F.E.A.S.T. has launched a free online dictionary for parents that explains the complex terms and concepts used in the diagnosis and treatment of eating disorders, eating disturbances and a wide range of co-existing conditions.<o:p></o:p></p>
<p class="MsoNormal"><span> </span>An international eating disorders organization has launched the world’s first comprehensive dictionary on eating disorders for parents and caregivers.<o:p></o:p></p>
<p class="MsoNormal">The F.E.A.S.T. Eating Disorders Glossary<span>  </span>provides definitions and explanations for more than 400 terms and concepts used in the eating disorders field. F.E.A.S.T. (Families Empowered and Supporting Treatment of Eating Disorders Treatment) is an international non-profit organization supporting parents and caregivers of children suffering from eating disorders.<o:p></o:p></p>
<p class="MsoNormal">The new free online reference &#8212; http://glossary.feast-ed.org &#8212; contains entries for 35 different eating disorders and disturbances, along with 25 disorders or conditions that often are associated or co-exist with a clinical eating disorder. In addition, detailed explanations are provided for hundreds of terms used in the modern science of eating disorders, including diagnosis, psychological and therapeutic approaches, medical management of symptoms and complications, biology, pharmacology and clinical research.<o:p></o:p></p>
<p class="MsoNormal">The aim of the glossary is to give parents facing an eating disorders crisis an authoritative, easy-to-use reference that will help them quickly “get up to speed” on the technical terms and concepts they will encounter as they consider various treatment options for their child or adolescent, said Laura Collins, executive director of F.E.A.S.T.<o:p></o:p></p>
<p class="MsoNormal">“The eating disorders field is filled with arcane vocabulary and very complex concepts,” <st2:personname w:st="on"><st1:title w:st="on">Ms.</st1:title>  <st1:sn w:st="on">Collins</st1:sn></st2:personname> said. “Parents need to understand these terms and concepts so they can understand what their doctors are telling them. This will enable them to ask the right questions and will ultimately empower them to play a productive role as a key member of the treatment team they put together to manage their child’s recovery.”<o:p></o:p></p>
<p class="MsoNormal">Though edited for a lay public, the F.E.A.S.T. eating disorders dictionary may also prove useful to non-specialist professionals and general practitioners, Ms. <st1:sn w:st="on">Collins</st1:sn> said, noting that many nutritionists, psychologists and generalist doctors have not received formal training in the modern science of eating disorders.<o:p></o:p></p>
<p class="MsoNormal">Among the eating disorders explained in the glossary are: Anorexia Nervosa, Binge eating disorder, Bulimia nervosa , Compensatory Behaviors, Compulsive or compensatory exercise, Compulsive Overeating , Diabulimia, Eating Disorder not Otherwise Specified (EDNOS), Extreme exercising, Feeding Disorder of Infancy or Early Childhood , Female Athlete Triad , Food avoidance emotional disorder, Food refusal , Functional dysphagia, Hyperphagia, Marasmus , Muscle dysmorphia (also called Reverse anorexia or Bigorexia), Night Eating Syndrome (NES), Obesity, Orthorexia, PANDAS , Pathorexia, Pervasive refusal syndrome, Pica, Picky eating, Prader Willi syndrome (PWS), Purging disorder, Restrictive eating, Rumination disorder, and Selective eating.<o:p></o:p></p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2009/10/26/comprehensive-eating-disorders-dictionary-for-parents-launched-by-feast/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Cause and Treatment of Heart Disease</title>
		<link>http://www.epatienthealthcare.com/blog/2009/10/24/the-cause-and-treatment-of-heart-disease/</link>
		<comments>http://www.epatienthealthcare.com/blog/2009/10/24/the-cause-and-treatment-of-heart-disease/#comments</comments>
		<pubDate>Sat, 24 Oct 2009 22:43:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Medical Studies]]></category>
		<category><![CDATA[Nutritional Blends]]></category>
		<category><![CDATA[Vitamins - Supplements]]></category>
		<category><![CDATA[cause of heart disease]]></category>
		<category><![CDATA[cholesterol]]></category>
		<category><![CDATA[diet]]></category>
		<category><![CDATA[fats]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[free-radical]]></category>
		<category><![CDATA[GE E-Care]]></category>
		<category><![CDATA[heart]]></category>
		<category><![CDATA[heart disease]]></category>
		<category><![CDATA[Medical Advances]]></category>
		<category><![CDATA[processed food]]></category>
		<category><![CDATA[thyroid]]></category>
		<category><![CDATA[treatment of heart disease]]></category>
		<category><![CDATA[USTM Patients]]></category>

		<guid isPermaLink="false">http://www.gembpatients.com/blog/2009/10/24/the-cause-and-treatment-of-heart-disease/</guid>
		<description><![CDATA[The Cause and Treatment of Heart Disease The cause of heart disease is not animal fats and cholesterol but rather a number of factors inherent in modern diets, including excess consumption of vegetables oils and hydrogenated fats; excess consumption of refined carbohydrates in the form of sugar and white flour; mineral deficiencies, particularly low levels [...]]]></description>
			<content:encoded><![CDATA[<p><!--[if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves /> <w:TrackFormatting /> <w:PunctuationKerning /> <w:ValidateAgainstSchemas /> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF /> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables /> <w:SnapToGridInCell /> <w:WrapTextWithPunct /> <w:UseAsianBreakRules /> <w:DontGrowAutofit /> <w:SplitPgBreakAndParaMark /> <w:DontVertAlignCellWithSp /> <w:DontBreakConstrainedForcedTables /> <w:DontVertAlignInTxbx /> <w:Word11KerningPairs /> <w:CachedColBalance /> </w:Compatibility> <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> <m:mathPr> <m:mathFont m:val="Cambria Math" /> <m:brkBin m:val="before" /> <m:brkBinSub m:val="&#45;-" /> <m:smallFrac m:val="off" /> <m:dispDef /> <m:lMargin m:val="0" /> <m:rMargin m:val="0" /> <m:defJc m:val="centerGroup" /> <m:wrapIndent m:val="1440" /> <m:intLim m:val="subSup" /> <m:naryLim m:val="undOvr" /> </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"   DefSemiHidden="true" DefQFormat="false" DefPriority="99"   LatentStyleCount="267"> <w:LsdException Locked="false" Priority="0" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Normal" /> <w:LsdException Locked="false" Priority="9" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="heading 1" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9" /> <w:LsdException Locked="false" Priority="39" Name="toc 1" /> <w:LsdException Locked="false" Priority="39" Name="toc 2" /> <w:LsdException Locked="false" Priority="39" Name="toc 3" /> <w:LsdException Locked="false" Priority="39" Name="toc 4" /> <w:LsdException Locked="false" Priority="39" Name="toc 5" /> <w:LsdException Locked="false" Priority="39" Name="toc 6" /> <w:LsdException Locked="false" Priority="39" Name="toc 7" /> <w:LsdException Locked="false" Priority="39" Name="toc 8" /> <w:LsdException Locked="false" Priority="39" Name="toc 9" /> <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption" /> <w:LsdException Locked="false" Priority="10" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Title" /> <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font" /> <w:LsdException Locked="false" Priority="11" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtitle" /> <w:LsdException Locked="false" Priority="22" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Strong" /> <w:LsdException Locked="false" Priority="20" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Emphasis" /> <w:LsdException Locked="false" Priority="59" SemiHidden="false"    UnhideWhenUsed="false" Name="Table Grid" /> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text" /> <w:LsdException Locked="false" Priority="1" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="No Spacing" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 1" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 1" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 1" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 1" /> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision" /> <w:LsdException Locked="false" Priority="34" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="List Paragraph" /> <w:LsdException Locked="false" Priority="29" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Quote" /> <w:LsdException Locked="false" Priority="30" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Quote" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 1" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 1" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 1" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 1" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 1" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 2" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 2" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 2" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 2" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 2" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 2" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 2" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 2" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 2" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 3" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 3" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 3" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 3" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 3" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 3" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 3" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 3" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 3" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 4" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 4" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 4" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 4" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 4" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 4" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 4" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 4" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 4" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 5" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 5" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 5" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 5" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 5" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 5" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 5" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 5" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 5" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 6" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 6" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 6" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 6" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 6" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 6" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 6" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 6" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 6" /> <w:LsdException Locked="false" Priority="19" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis" /> <w:LsdException Locked="false" Priority="21" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis" /> <w:LsdException Locked="false" Priority="31" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference" /> <w:LsdException Locked="false" Priority="32" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Reference" /> <w:LsdException Locked="false" Priority="33" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Book Title" /> <w:LsdException Locked="false" Priority="37" Name="Bibliography" /> <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading" /> </w:LatentStyles> </xml><![endif]--></p>
<p><!--   /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:roman; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin-top:0in; 	margin-right:0in; 	margin-bottom:10.0pt; 	margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.0in 1.0in 1.0in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --><!--[if gte mso 10]><br />
<mce:style><!    /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;}  --></p>
<p><!--[endif]--></p>
<p class="MsoNormal"><strong><span style="font-size: 14pt; line-height: 115%;">The Cause and Treatment of Heart Disease</span></strong></p>
<p class="MsoNormal">The cause of heart disease is not animal fats and cholesterol but rather a number of factors inherent in modern diets, including excess consumption of vegetables oils and hydrogenated fats; excess consumption of refined carbohydrates in the form of sugar and white flour; mineral deficiencies, particularly low levels of protective magnesium and iodine; deficiencies of vitamins, particularly of vitamin C, needed for the integrity of the blood vessel walls, and of antioxidants like selenium and vitamin E, which protect us from free radicals; and, finally, the disappearance of antimicrobial fats from the food supply, namely, animal fats and tropical oils. These once protected us against the kinds of viruses and bacteria that have been associated with the onset of pathogenic plaque leading to heart disease.</p>
<p class="MsoNormal">While serum cholesterol levels provide an inaccurate indication of future heart disease, a high level of a substance called homocysteine in the blood has been positively correlated with pathological buildup of plaque in the arteries and the tendency to form clots—a deadly combination. Folic acid, vitamin B<sub>6</sub>, vitamin B<sub>12</sub> and choline are nutrients that lower serum homocysteine levels. These nutrients are found mostly in animal foods.</p>
<p class="MsoNormal">The best way to treat heart disease, then, is not to focus on lowering cholesterol—either by drugs or diet—but to consume a diet that provides animal foods rich in vitamins B<sub>6</sub> and B<sub>12</sub>; to bolster thyroid function by daily use of natural sea salt, a good source of usable iodine; to avoid vitamin and mineral deficiencies that make the artery walls more prone to ruptures and the buildup of plaque; to include the antimicrobial fats in the diet; and to eliminate processed foods containing refined carbohydrates, oxidized cholesterol and free-radical-containing vegetable oils that cause the body to need constant repair.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2009/10/24/the-cause-and-treatment-of-heart-disease/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk
Page Caching using disk (enhanced)
Database Caching 11/58 queries in 0.012 seconds using disk
Object Caching 1382/1433 objects using disk

Served from: www.epatienthealthcare.com @ 2012-02-12 02:11:38 -->
